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Abstract 
BMP15 is an oocyte-secreted growth factor that is critical for ovarian follicular 
development and fertility in mammals. To improve our understanding of the species-
specific effects of BMP15 on fertility, the aim of this study was to elucidate the molecular 
forms of BMP15 in mammals with high (rat and pigs) and low (sheep and deer) litter sizes. 
Western blotting experiments were undertaken using a monoclonal antibody directed 
against a semi-conserved area on the mature region of E.coli-expressed ovine BMP15.  
Within the oocyte lysate of all species tested, the predominant form was promature 
BMP15, although mature BMP15 was also present. Within oocyte-conditioned media of 
sheep, pigs and deer, the promature:mature BMP15 ratio dropped significantly from what 
was seen inside the oocyte, with promature BMP15 only slightly predominant in deer, and 
relatively equal amounts of each protein were present in pigs and sheep. No BMP15 was 
detected in the oocyte-conditioned media of rats. Cross-linking studies did not provide any 
evidence of BMP15/BMP15 homodimers or BMP15/GDF9 heterodimers in any species 
tested.  
Intra-oocyte levels of both promature and mature BMP15, from highest to lowest, were 
detected in deer, followed by sheep and pigs (similar), and then rats (significantly lower). 
In the oocyte-conditioned media, with the exception of the rat where BMP15 was absent, 
there was a similar pattern of promature BMP15 levels observed between species, whereas 
mature BMP15 levels showed no inter-species variation.  
In summary, the molecular forms and relative amounts of BMP15 protein differ across 
species. Generally, high BMP15 levels were associated with low litter size; however the pig 
is an exception. Furthermore, the molecular forms observed in this study differed from 
those reported in studies using recombinant BMP15 suggesting that recombinantly-
expressed protein may not provide a fair representation of native BMP15. 
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Chapter 1: Introduction 
1.1 The Transforming Growth Factor-Beta (TGF-β) 
Superfamily of Proteins 
 
1.1.1 Overview 
 
The TGF-β superfamily of proteins is a large group of structurally-related proteins that 
regulate a range of cellular processes throughout the body in vertebrates, including 
development, growth, differentiation, adhesion, positioning, movement and reproductive 
function (Chang et al., 2002; Lin et al., 2006; Massagué, 2012).  The superfamily can be 
divided into four subfamilies based on the genetic structure and origin of each protein: 
namely the activins/inhibins, the TGF-β subfamily, the bone morphogenetic proteins 
(BMPs) and growth differentiation factors (GDFs) and finally, a group consisting of distant 
and diverse members which don’t fall into any of the first three subfamilies (Mueller and 
Nickel, 2012). The activin/inhibin subfamily have roles including the regulation of follicle-
stimulating hormone (FSH) expression and the menstrual cycle, while the TGFβs subfamily 
members regulate tissue homeostasis, and have roles in cell proliferation, cell 
differentiation, and embryonic development (Macias et al., 2015; McCartney-Francis and 
Wahl, 1994; Mueller and Nickel, 2012). The BMPs and GDFs form the largest subfamily with 
more than 15 members, and regulate limb, embryonic, skeletal and other organ 
development (Mueller and Nickel, 2012). The members of the fourth and final subfamily 
do not have a defined relationship other than they all fall outside of the other three 
subfamilies whilst still meeting the classification criteria for TGF-β proteins, and includes 
both BMP15 and GDF9 (Mueller and Nickel, 2012).  
Many important growth factors involved in mammalian folliculogenesis are members of 
the TGF-β superfamily, and are expressed in a coordinated manner to regulate the various 
stages of development (Knight and Glister, 2006; Paradis et al., 2009). These include BMP4 
and BMP7 by theca cells, inhibins and activins by granulosa cells (GCs), and BMP15 and 
GDF9 by oocytes (Shimasaki et al., 2004a). It is important to understand the shared 
characteristics of the TGF-β superfamily considering that so many members play a role in 
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mammalian fertility, and that these members share structural characteristics and a 
common ancestry. 
 
1.1.2 General Structure of TGF-β Superfamily Proteins 
 
There are over 35 members in the TGF-β superfamily in vertebrates, all of which are 
classified based on their similar structure (Knight and Glister, 2006). Members are 
synthesised as a preproprotein consisting of a signal peptide (the pre-region), a large 
precursor segment with a chaperone function (the proregion), and a mature domain at the 
carboxy-terminal (the mature region) (see Figure 1.1 A) (Chang et al., 2002; Shimasaki et 
al., 2004a). It was previously suggested that the proregion was required for correct folding 
and dimerization of the mature TGF-β ligands, however recombinant forms of the mature 
segment alone have been shown to form dimers and fold correctly in vitro which indicates 
that the proregion is not always required for these purposes (Fairlie et al., 2001; Harrison 
et al., 2011; Mueller and Nickel, 2012; Ruppert et al., 1996). The mature segment is 
preceded by a conserved RXXR motif that is recognised by proprotein convertases such as 
furin (Juengel and McNatty, 2005; Seidah and Chrétien, 1999). Under the current model of 
protein processing, the pre-region is removed following translocation into the rough 
endoplasmic reticulum (RER) and then the proprotein forms a dimer, which in turn is 
enzymatically cleaved at the RXXR region leaving a mature dimer (Juengel and McNatty, 
2005; McPherron and Lee, 1993). Post-translational processing in the ER and Golgi 
apparatus, such as N- and O-glycosylation, may be essential for the bioactivity of the 
proteins (Brunner et al., 1992; Hang et al., 2014; Hashimoto et al., 2005; Miyazono and 
Heldin, 1989; Saito et al., 2008). 
In many cases, even though the proregion has been enzymatically cleaved, it may remain 
associated with the mature region through non-covalent interactions and continue to 
regulate its activity. In such cases, the mature protein bioactivity is often delayed by the 
presence of the associated proregion until it is actively removed (see Figure 1.1 B) 
(Hauburger et al., 2009; McIntosh et al., 2008; McMahon et al., 1996; Mueller and Nickel, 
2012). The proregion has more sequence variability between TGF-β members than the 
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mature region, with some members forming disulphide bonds between two proregions 
while others do not (see Figure 1.1 B) (Mueller and Nickel, 2012; Shi et al., 2011). These 
differences may affect the strength with which the proregions remain associated with their 
corresponding mature segments (Mueller and Nickel, 2012). 
In general, members of the TGF-β superfamily have seven conserved cysteine residues 
within the mature segment. Three pairs of these cysteine residues form intramolecular 
disulphide bonds, causing a 3-dimensional cysteine knot structure to form. In addition, one 
of the residues in each mature protein forms a covalent intermolecular disulphide bond 
with another mature protein to form a mature dimer (see Figure 1.1 B) (Lin et al., 2006; 
McPherron and Lee, 1993; Shimasaki et al., 2004a). These mature dimers are usually 
homodimers, that is a dimer of two matching mature protein subunits, however 
heterodimers between closely related proteins within the TGF-β superfamily have been 
reported (Guo and Wu, 2012; Shimasaki et al., 2004a). These heterodimers tend to be 
characterised by unique and generally-enhanced functions, compared to their homodimer 
counterparts (Guo and Wu, 2012). A small subset of the TGF-β superfamily, namely GDF3, 
GDF9, BMP15, Lefty1 and Lefty2, lack the seventh cysteine residue which means they can’t 
form the disulphide bridge between the two subunits (Mueller and Nickel, 2012; Shimasaki 
et al., 2004a). Instead, they may form as non-covalent homodimers and heterodimers (Lin 
et al., 2006; McIntosh et al., 2008; Mottershead et al., 2015).  
 
1.1.3 General Receptor Structure and Signalling Mechanisms of 
TGF-β Superfamily Proteins 
 
Members of the TGF-β superfamily are cytokines which bind to receptor serine kinases on 
the surface of cells. There are hundreds of serine/threonine kinases, however only twelve 
are cell surface-bound receptors, all of which are receptors for TGF-β superfamily members 
(Macias et al., 2015). These receptors generally phosphorylate Smad [from Caenorhabditis 
elegans SMA (small) and Drosophila mothers against decapenthaplegic] related  proteins, 
allowing them to form complexes that act as transcription factors to regulate gene 
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expression (Macias et al., 2015). The target genes depends upon a range of factors such as 
the receptor complex to which the TGF-β member binds, the Smad proteins involved, the 
Smad transcriptional co-factors employed, the epigenetic status, as well as other DNA 
binding partners and mediators (see Figure 1.2) (Massagué, 2012; Massagué et al., 2005). 
These factors are highly contextual and vary depending on the type and developmental 
stage of the target cell, giving the TGF-β family members a vastly complex arsenal of 
possible cellular effects (Macias et al., 2015; Massagué, 2012).  
The twelve serine/threonine kinase surface receptors fall into two categories, namely the 
type I and type II receptors. Both receptor types have an intracellular domain with 
serine/threonine kinase activity, a single pass transmembrane domain, and an extracellular 
ligand binding domain with a three-finger toxin fold (de Caestecker, 2004). The two 
categories are differentiated by the presence of a region rich in glycine/serine (GS-box) on 
the intracellular side of type I receptors, and its absence in type 2 receptors (see Figure 1.1 
C) (Mueller and Nickel, 2012). In general, the binding of the dimeric ligand causes two type 
I and two type II receptors to assemble in a complex (Massagué, 2012). Most TGF-β 
members appear to bind to a type II receptor first, and then subsequently recruit a type I 
receptor, however many BMPs (not including BMP15) appear to have a greater affinity for 
type I receptors than type II receptors and may prefer to bind a pre-formed receptor 
complex made of type I and type II receptors (Mueller and Nickel, 2012; Rosenzweig et al., 
1995; ten Dijke et al., 2003). Once in the complex, the type II receptors phosphorylate and 
activate the type I receptors, and these then phosphorylate and activate the Smad 
signalling proteins and/or other signal delivery factors (Massagué, 2012; Wrana et al., 
1994).   
There are seven type I (ALK1-7) and five type II (ActR-II, ActR-IIB, TβR-II, BMPR-II and AMHR-
II) cell-surface serine/threonine receptors, and these are able to form unique combinations 
with specificities for the various TGF-β superfamily ligands (Mueller and Nickel, 2012). The 
expression pattern of these receptors may affect how different cells respond to the same 
TGF-β ligands (Massagué, 2012). The level of signal a cell receives from stimulation by a 
TGF-β  superfamily ligand can be altered by several factors such as the concentration of the 
TGF-β  ligand present, the ligand subtype and its affinity for the receptor, the presence of 
ligand binding protein or traps which can capture the TGF-β ligands and prevent binding, 
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and also the presence of mediators which regulate the release of the ligand from the traps 
(Cheifetz et al., 1987; Massagué, 2012; Zakin and De Robertis, 2010). Some TGF-β ligands 
may bind the receptors of other TGF-β members without causing any downstream signal 
activation, and thus inhibit their activity (Massagué, 2012). An example of this are the 
inhibins, which can block activin from binding its receptors (Zhu et al., 2012).   
The first Smads to undergo phosphorylation by the type I receptor are receptor-regulated 
Smad molecules (rSmads). The rSmads which are phosphorylated by the type I receptor are 
either Smad1, 5 and 8, or Smad2 and 3 depending on the ligand and the type I receptor 
involved (Massagué, 2012). The rSmads then form a complex with Smad4 (common-
mediator Smad, or cSmad) which then translocates into the nucleus and regulate gene 
expression (Mueller and Nickel, 2012). Smad4 can be inhibited by inhibitory Smads (iSmads; 
Smad6 and 7) that can act by forming an inactive complex with Smad4 or by binding the 
activated type I receptor in place of rSmads and thus prevent their activation (see Figure 
1.2) (Hariharan and Pillai, 2008; Mueller and Nickel, 2012). Other Smad independent 
pathways exist for some TGF-β superfamily members, such as the mitogen activated 
protein kinase (MAPK) pathway (Moore et al., 2003; Moustakas and Heldin, 2005; Reader 
et al., 2011; Sano et al., 1999).   
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Figure 1.1. The structure of TGF-β superfamily proteins and their receptors. (A) General structure of 
TGF-β superfamily proteins. TGF-β superfamily members are synthesised as prepromature proteins with 
an N-terminal signal peptide (the preregion) which is removed upon translocation into the RER, a large 
proregion with chaperone function, and mature peptide at the C-terminal. The mature peptide is 
preceded by a RXXR residue which is targeted by proteases such as furin. (B) The protein forms a dimeric 
complex. Represented by a single asterisk (*) are the intermolecular disulphide binds found between 
the prodomains of some members of the TGF-β superfamily such as those within the TGF-β subfamily. 
The double asterisk (**) represents the disulphide bond between the mature protein dimer in all TGF-β 
superfamily members except for BMP15, GDF9, GDF3, Lefty1 and Lefty2. The protein may exist as either 
a promature dimer, a mature dimer with non-covalently associated proregions or a mature dimer which 
fully disassociated from the proregions. The triple asterisk (***) represents non-covalent association. 
(C) The structure of the type I and type II TGF-β receptors. The ligand binding domain (LB domain) lies 
on the extracellular side of the cell membrane and is connected to the intracellular kinase domain by a 
single pass transmembrane region. The type I receptor has a glysine/serine rich region (GS Box) on the 
intracellular side of the membrane which plays a role in the phosphorylation of downstream Smad 
proteins. The figures were created using Adobe Illustrator with descriptions in Massagué, 2012 and 
Mueller & Nickel, 2012 used as a guide. 
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Figure 1.2. The TGF-β Smad signalling pathway in target cells. (1) TGF-β binds to a complex of type I 
(T1) and type II (T2) receptors on the surface of the target cell. Generally, the TGF-β dimeric ligand will 
bind a pair of type II receptors which then recruit a pair of type I receptors. (2) The constitutively active 
type II receptors then phosphorylate the type I receptors in the complex. (3) The phosphorylated type I 
receptors then bind and phosphorylate rSmads. At this stage, a range of signal mediators such as the 
common-mediator Smad4 (Co) bind the rSmads. Inhibitory Smads such as Smad 6 and 7 (In) can inhibit 
the signalling through either binding Smad4 to form an inactive complex, or by binding the 
phosphorylated type I receptor in place of the rSmads, preventing their phosphorylation. (4) Once the 
phosphorylated rSmads have successfully formed a complex with the required signal mediators they 
translocate into the nucleus and interact with a range of other cell lineage specific transcription factors 
(TF). The range of transcription factors and other signal mediators in the complex determines which 
genes are targeted and whether they are activated or repressed. The epigenetic status of the target 
gene determines whether it is accessible to the rSmad complex (shaded in red and green, where red 
represents an inaccessible gene while green is accessible).  The components of the transcription complex 
must match the correct enhancer elements preceding the target gene for transcription to occur. 
Successful transcription is marked by a green tick.  The figures were created using Adobe Illustrator with 
descriptions and images in Massagué, 2012 used as a guide. 
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1.2 BMP15 and GDF9  
 
1.2.1 Overview 
 
In the past, it was believed that folliculogenesis was controlled solely by endocrine factors 
such as protein and steroidal hormones. However, in recent years the importance of intra-
follicular paracrine signals has been established by an ever increasing abundance of studies 
(Paulini and Melo, 2011). These studies have revealed the essential role of paracrine 
communication via a range of oocyte secreted factors (OSFs), between a developing oocyte 
and the surrounding cumulus and granulosa cells of a growing follicle (Gilchrist et al., 2008; 
Otsuka et al., 2011). Two OSFs that have been the subject of a significant amount of 
research are BMP15 (previously named GDF9B), which is the protein of interest in this 
study, and GDF9. It is important to include GDF9 when considering BMP15 as the two 
proteins have closely-related and largely intertwining roles. Their roles extend from the 
very early stages of follicular development, as early as the primordial follicle stage, and 
continue right through to ovulation, and thus form a vital component of mammalian 
fertility (Sun et al., 2010). Their roles appear to be species-specific, and include the 
regulation of the intra-follicular somatic cells. In particular, these two OSFs promote 
proliferation of, and steroidogenesis in, granulosa cells,  inhibit apoptosis and luteinisation 
of these cells and regulate the differentiation of a subset of granulosa cells into specialised 
cumulus cells (Dragovic et al., 2007; Gilchrist et al., 2008; Knight and Glister, 2006; Li et al., 
2000; McNatty et al., 2005a; Otsuka and Shimasaki, 2002).  
GDF9 was the first of the two proteins to be discovered, with its discovery in the mouse 
ovary in 1993 (McPherron and Lee, 1993). BMP15 was discovered a few years later in 1998 
(Dube et al., 1998). They are the most homologous of all the OSFs, and are more closely 
related to each other (53% homology in mice) than they are to any other member of the 
TGF-β superfamily of proteins (Laitinen et al., 1998). The current evidence is that in rodents, 
sheep, pigs, deer and a range of other mammals,  both Bmp15 and Gdf9 mRNA are only 
expressed by the oocyte within the follicle (Aaltonen et al., 1999; Bodensteiner et al., 2000; 
Juengel and McNatty, 2005; Laitinen et al., 1998). However, despite being oocyte-specific 
within the ovary, BMP15 and GDF9 has been detected in extra-ovarian tissues such the 
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testis and pituitary gland in some species (Fitzpatrick et al., 1998; Otsuka and Shimasaki, 
2002; Wang et al., 2009).  
The relative expression levels of Gdf9 and Bmp15 mRNA has been shown to be highly 
variable between different mammalian species. However, relatively equal- or low-ratios of 
GDF9:BMP15 was generally associated with low or mono-ovulatory species such as sheep, 
cows and red deer, while a high GDF9 to BMP15 ratio was found in poly-ovulatory species 
such as rats (Crawford and McNatty, 2012). This trend aligns well with a number of studies 
where it was found GDF9, but not BMP15, was essential for follicular development in 
polyovulatory species such as mice, while both proteins were required for normal 
folliculogenesis in species with a low ovulation rate, such as the sheep (Galloway et al., 
2000; Hanrahan et al., 2004; Yan et al., 2001). There were a few notable outliers to the 
trend such as the pig, which had a low GDF9:BMP15 ratio despite producing large litters 
(i.e. high ovulation rate species) (Crawford and McNatty, 2012).   
 
1.2.2 Structure 
 
The primary structure of both proteins follows the same basic structure found in all TGF-β 
family members as described in Section 1.1.2. They are produced as preproproteins, with 
an N-terminal signal peptide (pre-region) which is removed upon translocation into the 
RER, a proregion, and then mature region at the C-terminal (Chang et al., 2002). The 
proregion is cleaved from the mature region by proprotein convertases at a four amino acid 
motif (RXXR) directly preceding the N-terminal of the mature peptide (Juengel and 
McNatty, 2005). BMP15 and GDF9 belong to a small group within the TGF-β superfamily 
which lack the fourth of the seven conserved cysteines within the sequence of their mature 
peptide, and as such are unable to form a covalent bond during dimer formation (Mueller 
and Nickel, 2012; Shimasaki et al., 2004a). The lack of a covalent bond within the dimers is 
presumed to allow for a more flexible array of possible interactions between monomer 
units than is traditionally seen with other TGF-β family members (Chang et al., 2002). 
Modelling of the BMP15 and GDF9 heterodimer interface reveals similarities to the 
homodimer interface for each protein, and demonstrates that a stable non-covalent 
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heterodimer complex is possible (Mottershead et al., 2015). Numerous in vitro studies have 
observed homodimers, heterodimers and even multimers between the two recombinant 
proteins (Liao et al., 2003; Lin et al., 2006; McIntosh et al., 2008; Mottershead et al., 2015; 
Peng et al., 2013a; Shimasaki et al., 2004a) however to date, dimers between native oocyte-
produced proteins in solution are yet to be identified.  
The activity of BMP15 and GDF9 varies greatly between species, with differences in the 
molecular forms of each protein likely to play a large role in this. Granulosa cell expansion 
assays with recombinant human and mouse BMP15 and GDF9 heterodimers revealed a 
~3000 fold increase in activity with human heterodimers compared to their BMP15 
homodimer counterparts, whilst the human GDF9 homodimers had little to no activity 
(Peng et al., 2013a). Conversely, there was a ~10 to 30 fold increase in activity with mouse 
heterodimers compared to their GDF9 homodimer counterpart, while mouse BMP15 
homodimers were essentially inactive (Peng et al., 2013a). This highlights the difference in 
activity between homodimers and heterodimers of each protein, and also the species 
specific nature of the activity of each protein form (Peng et al., 2013a).  
Like many other members of the TGF-β family, the proregion has been shown to remain 
non-covalently associated with both GDF9 and BMP15 after cleavage at its protease 
processing site, and it may have a role in regulating the bioactivity of each protein along 
with their cooperative interactions (McIntosh et al., 2012, 2008). It has been demonstrated 
that recombinant mouse BMP15 is secreted in a cleaved and uncleaved form, while mouse 
GDF9 is only secreted in a cleaved form. The cleaved proregion tends to remain non-
covalently associated with the mature region of each protein, however the proregion only 
remains weakly associated with mouse GDF9 which places the mature peptide in a highly 
bioactive state (McIntosh et al., 2008). In contrast, the prodomain of human GDF9 remains 
strongly associated following cleavage rendering the mature peptide less bioactive 
(Mottershead et al., 2008; Simpson et al., 2012). The role of the associated proregion in 
regulating the activity of each protein appears to vary significantly amongst species 
(Mottershead et al., 2008; Simpson et al., 2012). 
There is evidence to suggest that the proproteins of TGF-β family members dimerize before 
cleavage of the proregion occurs (Hogan, 1996). The efficiency of the dimerization and 
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subsequent proteolytic cleavage may be important for regulating the bioactivity of the 
protein (Constam and Robertson, 1999; Kusakabe et al., 2008). Furthermore, a study with 
recombinant BMP15 and GDF9 found that coexpression of the two proteins led to impaired 
cleavage efficiency of the proregion from each protein compared to when each protein was 
expressed independently. This indicates that the proproteins may form a heterodimeric 
complex which is less efficiently processed than their homodimeric counterparts (Liao et 
al., 2003).  
As with a number of other TGFβ proteins, post-translational processing through 
phosphorylation and/or glycosylation (both N-linked and O-linked) may play an important 
role in the bioactivity of BMP15 and GDF9 (Hashimoto et al., 2005; McMahon et al., 2008b; 
Saito et al., 2008). N-linked and O-linked glycosylation has been shown to be important in 
the function of a range of proteins. For example, O-linked and N-linked oligosaccharides 
are essential for maintaining the half-life and bioactivity of various glycoprotein hormones, 
as well as affecting their receptor binding qualities and subsequent signal transduction 
(Fares, 2006). BMP15 is believed to have five glycosylation sites, with two in the mature 
region, while GDF9 has four, with one in the mature region (Dube et al., 1998; Hayashi et 
al., 1999). A study using recombinant human BMP15 and GDF9 demonstrated that both 
proteins are phosphorylated and that the phosphorylation was essential for their 
bioactivity (McMahon et al., 2008b). Furthermore, it was shown that the dephosphorylated 
forms of each protein could have an antagonistic effect toward the phosphorylated form 
of either protein (McMahon et al., 2008b). While the current evidence points towards an 
important role in phosphorylation and glycosylation in the function of both proteins, the 
number of studies is still very limited. 
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1.2.3 Sequence 
 
Many of the species-specific differences in activity of the two proteins may be explained by 
small changes in the amino acid sequence between species (Al-Musawi et al., 2013). Site-
directed mutagenesis identified four variable residues in the prodomain that could explain 
the different levels of expression of BMP15 between humans, sheep and mice, as well as a 
number of residues which were responsible for determining the species-specific affinity to 
the type I receptor (Al-Musawi et al., 2013). Moreover, the variation of a single amino acid 
residue at position 391 in the GDF9 mature region of humans (glycine), compared to mice 
(arginine), resulted in the protein being secreted in a latent form (with a non-covalently 
associated prodomain) whilst murine GDF9 was secreted in an active form (Simpson et al., 
2012). This residue formed part of the type I receptor binding domain, and the murine form 
of the residue greatly increased the affinity of the GDF9 for its receptor on granulosa cells. 
The Gly(391) residue observed in the human form was also found to be present in all other 
species studied except for a small group of species with high litter size, including rats, mice, 
and hamsters, and also the mono-ovulatory common brushtail possum, all of which had 
the high affinity murine form (Arg(391)) (Simpson et al., 2012). These studies indicate that 
small key differences in the amino acid sequence of GDF9 and BMP15 may explain some of 
the variation in follicular development and fertility between different mammals.  
The genes for both proteins contain two exons flanking a single intron. The signal peptide 
sequence is encoded on the first exon, the proregion is encoded on portions of both exons, 
and finally the mature region is found solely on the second exon (Dube et al., 1998; Incerti 
et al., 1994). The gene for BMP15 is located on the X-chromosome in all mammalian species 
studied to date whereas GDF9 is autosomally-located (Dube et al., 1998; National Center 
for BiotechnoIogy Information, NCBI). The autosomal location of GDF9 varies greatly 
between different mammalian species (for example, chromosome 5 in humans, 
chromosome 10 in rats, chromosome 11 in mice, chromosome 7 in the cow and 
chromosome 2 in pigs) (NCBI).  
Of the four mammalian species involved in this study (rats, pigs, sheep and deer), BMP15 
protein shows the greatest sequence similarity between sheep and deer. Only three 
residue differences are present in the mature peptide, along with a further three 
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differences are in the proregion (see Figure 1.3). The next most homologous species is the 
pig, with four unique residues in the mature peptide, one in the RXXR cleavage region, and 
a further sixteen in the proregion. Notable residues that were unique in the pig were in a 
highly conserved region near the C-terminal end of the mature peptide (two residues), and 
in the RXXR cleavage region (one residue). The rat has vastly more unique residues than 
any of the other three species, with 24 in the mature peptide, two in the RXXR cleavage 
region, and 74 in the proregion. Most notable are two unique residues in the RXXR cleavage 
region and the clustering of unique residues either side of the cleavage region. The 
molecular weight of the promature and mature peptides based on the sequence were 
calculated using the ExPASy software (“ExPASy - Compute pI/Mw tool,” 2016). The mature 
peptide was predicted to be ~13.9-14.0 kDa in all four species, and the promature peptide 
was predicted to be ~44.9-45.0 kDa in rats, pigs and sheep, but could not be calculated in 
deer as the full sequence was not available. However, it is likely that the deer promature 
peptide is approximately the same size given the high homology shared with the sheep 
sequence. The GDF9 protein (sequence not provided) was predicted to be slightly larger 
than BMP15 in all four species, with a promature protein between 49.7 and 51.8 kDa, and 
the mature protein around 15.4 to 15.6 kDa. These size predictions are based on the 
sequence alone, and do not take into account any potential post-translational 
modifications that may occur at potential glycosylation and phosphorylation sites. 
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Figure 1.3. The BMP15 sequence in rats, pigs, sheep and deer. The rat, pig and sheep BMP15 sequences 
were obtained from the UniProtKB database, and primary accession numbers are E9PTU9, Q8WMY6 
and Q9MZE2, respectively. The deer sequence was kindly donated by Dr J. Juengel (AgResearch 
Invermay, NZ). While the rat, pig and sheep sequences shown above span the full promature peptide 
sequence, the deer sequence only contains peptides from Exon 2 and therefore, is missing a portion of 
the proregion. The red shaded area corresponds to the proregion for each protein, and the green shaded 
region represents the mature peptide. There are black borders around the six conserved cysteine 
residues within the mature peptide which are involved in cysteine knot formation. The yellow segment 
between the proregion and mature region is the RXXR proprotein convertase target site. The letters for 
each protein residue are coloured according to their properties. The red residues are all the small, 
hydrophobic and aromatic amino acids except Y (A,V,F,P,M,I,L, and W), whereas the green residues are 
all the amino acids with hydroxyl, sulfhydryl and amine groups as well as G (S,T,Y,H,C,N,G, and Q). The 
blue residues are the amino acids with acidic side chains (D and E), and the purple residues are the 
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amino acids with basic side chains except for H (R and K). Above the sequence are coloured boxes which 
represent variation in the amino acid of one or more species away from the most common residue at 
that point. The yellow box represents variation in the rat residue, the purple box indicates variation in 
the pig residue, the light blue box indicates variation in the sheep residue and the dark blue box signifies 
variation in the deer residue. The red box represents a region where there are two different residues, 
each of which is shared by two species, and the green box represents a region where there all the 
residues are unique between species. Consensus between the four species at each point is represented 
by one of three symbols directly under the sequence. The asterisk (*) indicates that all four species share 
the same residue, the colon (:) indicates that they vary but share strongly similar properties, and the 
period (.) indicates that they vary but share weakly similar properties. The lack of any of the three 
symbols indicates that as a whole, the residues of all four species are highly varied at that point. 
 
1.2.4 Signalling Pathways 
 
As with all TGF-β family proteins, both BMP15 and GDF9 act on their target cells via a 
receptor complex made up of type I and type II receptor Serine/Threonine kinases (as 
described in Section 1.1.3) (Paulini and Melo, 2011). Within the receptor complex, the type 
II receptors are constitutively active, and once they bind the ligand they recruit, 
phosphorylate and activate the type I receptors. The Type I receptors then phosphorylate 
and activate certain receptor-specific Smad proteins (rSmads), which in turn translocate 
into the nucleus and regulate the transcription of certain genes (Juengel et al., 2004; 
McNatty et al., 2004). 
The mature region of BMP15 binds a complex consisting of the BMP type II receptor 
(BMPRII) and the type I receptor ALK6/BMPR1B. The binding and subsequent 
phosphorylation of ALK6 by BMPRII activates the Smads 1, 5 and 8 within the cell (Moore 
et al., 2003). The mature region of GDF9 also binds BMPRII however its binding recruits the 
type I receptor ALK5. This BMPRII/ALK5 complex signals through the Smads 2 and 3 
(Mazerbourg et al., 2004). The Smad 1/5/8 and Smad 2/3 pathways both involve 
cooperation with Smad4 before translocating into the nucleus and regulating the 
expression of certain genes associated with proliferation, expansion and luteinisation, such 
as pentraxin 3 (Ptx3), hyaluronan synthase 2 (Has2), and prostaglandin-endoperoxide 
synthase 2 (Ptgs2) (Mazerbourg et al., 2004; Moore et al., 2003; Peng et al., 2013a). As with 
some other members of the TGF-β superfamily, there is evidence that both BMP15 and 
GDF9 may also signal through the MAPK pathway, however this varies between species 
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(Moore et al., 2003; Reader et al., 2011). The epidermal growth factor receptor (EGFR)-
extracellular signal-regulated kinase 1 and 2 (ERK1/2) may be required by GDF9 alongside 
Smad2/3 for proper signalling to occur as ERK1/2 helps maintain Smad3 phosphorylation 
(Sasseville et al., 2010). It was believed that the synergistic interaction of BMP15 and GDF9 
together may involve the ERK1/2 (also known as MAPK3/1) signalling pathway alongside 
the Smad pathway (Mottershead et al., 2012). However, inhibitors of the ERK/MAPK and 
the p38-MPAK pathway did not affect the synergistic action of human GDF and BMP15 on 
granulosa cell proliferation rate so this appears unlikely (Reader et al., 2014). Other 
pathways such as the SRC kinase pathway also may play a role in the synergistic interaction 
of the two proteins (Mottershead et al., 2012).  
 
In the case of human and mouse granulosa cells, the potent action of the BMP15:GDF9 
heterodimer on follicle development is believed to work through a receptor complex of 
BMPRII receptors, together with an ALK 4/5/7 type I receptor and an ALK6 type I co-
receptor (Peng et al., 2013a). Binding of the heteromeric dimer causes the phosphorylation 
of Smads 2/3 in both species despite BMP15 homodimers being shown to signal through 
the Smad1/5/8 pathway (Mazerbourg et al., 2004; Moore et al., 2003; Peng et al., 2013a). 
Other studies have demonstrated that the MAPK signalling pathway may also be involved 
in signal transduction alongside the Smad 2/3 pathway (Mottershead et al., 2012). More 
recent studies using BMP15 and GDF9 heterodimers of both the promature and mature 
proteins (termed pro-cumulin and cumulin, respectively) have indicated they activate both 
the Smad2/3 and the Smad 1/5/8 signalling pathways within granulosa cells (Mottershead 
et al 2015). 
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1.2.5 Biological Effects 
 
1.2.5.1 Genetics Studies 
 
There have been extensive murine genetic knockout studies that investigated the role of 
BMP15 and GDF9 in fertility. The GDF9 null mice (Gdf9-/-) are completely infertile, with 
anovulation being a key characteristic of the genotype (Dong et al., 1996; Yan et al., 2001). 
On the other hand, homozygous BMP15 knockout mice (Bmp15-/-) only present a minor 
loss of fertility. Bmp15+/- mice have a normal fertility phenotype, while Gdf9+/- mice have 
an increased ovulation and cumulus cell expansion rate, and subsequently have increased 
fertility (Su et al., 2004). Interestingly, when a Bmp15-/- genotype is combined with a Gdf9+/- 
genotype, there are severe defects in the ovary and the mice are essentially sterile, with 
reduced production of proteins associated with cumulus cell expansion, and impaired 
follicle and oocyte development (Su et al., 2004; Yan et al., 2001). These studies suggest 
that both BMP15 and GDF9 play a role in fertility outcomes in mice, however BMP15 plays 
a minor role compared to GDF9. These observations also support the possibility of a 
functional interaction between the two proteins in vivo (Dong et al., 1996; Su et al., 2004; 
Yan et al., 2001).  
Various mutations in BMP15 and GDF9 genes have been discovered in sheep, and have 
subsequently been used in a range of studies to evaluate the role of the proteins in a low 
ovulatory species. Homozygous nullifying mutations within the BMP15 gene (BMP15-/-) in 
ewes causes complete infertility by halting follicle development beyond the primary stage. 
However, heterozygotes (BMP15+/-) with the same mutation have an increased ovulation 
rate and are more fertile than their wildtype counterparts (Galloway et al., 2000). This 
contrasts to that observed in BMP15-/- and BMP15+/- mice, as described above (Galloway et 
al., 2000; Su et al., 2004; Yan et al., 2001).  Similar observations were made in highly fertile 
sheep lines with non-conservative knockout mutations in either BMP15 or GDF9 (Hanrahan 
et al., 2004). The BMP15+/- and GDF9+/- genotypes resulted in an increased ovulation rate 
in ewes, however BMP15-/- OR GDF9-/- caused sterility, highlighting the equal importance 
of both GDF9 and BMP15 in sheep (Hanrahan et al., 2004). Interestingly, GDF9+/-/BMP15+/- 
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sheep exhibited an even greater ovulation rate than ewes that had a heterozygous 
mutation in either protein alone (Hanrahan et al., 2004).  
In humans, studies into genetic mutations in the BMP15 gene have shown that 
abnormalities in the protein may play a role in hypergonadotropic ovarian failure, primary 
ovarian insufficiency, premature ovarian failure, and the ovarian phenotype of women with 
Turners Syndrome (Di Pasquale et al., 2004; Laissue et al., 2006; Persani et al., 2014; 
Rossetti et al., 2009). BMP15 may have a role in polycystic ovarian syndrome (PCOS) 
however this remains controversial (Persani et al., 2014). Studies into genetic mutations in 
GDF9 suggest it could play a role a number of reproductive disorders such as PCOS, 
diminished ovarian reserve, premature ovarian failure and dizygotic twinning (Laissue et 
al., 2006; Persani et al., 2014; Wang et al., 2010, 2013). These studies suggest that secretion 
of adequate amounts of bioactive forms of both BMP15 and GDF9 may also be essential 
for maintaining proper reproductive function in humans. 
 
1.2.5.2 In vitro Bioassays 
 
Recombinant BMP15 from a range of species has been used in numerous in-vitro studies 
to investigate its biological effects. The role of BMP15 in rats was investigated using a rat 
granulosa cells (GC) bioassay. Recombinant BMP15 added to rat GC showed that BMP15 
was a strong stimulator of GC proliferation in a manner independent of follicle stimulating 
hormone (FSH) (Otsuka et al., 2000). It also caused a significant decrease in FSH-induced 
progesterone production, but not FSH-induced oestradiol production, suggesting BMP15 
can selectively regulate FSH action (Otsuka et al., 2000). The mechanism for this regulation 
may be the down-regulation of the FSH receptor (Otsuka et al., 2001). A similar effect of 
down-regulation of FSH-induced progesterone production was observed in sheep (Fabre et 
al., 2006).  
A study using recombinant human BMP15 and human GCs demonstrated that it also 
increases GC proliferation in a dose-dependent manner (Di Pasquale et al., 2004). Ovine 
BMP15 was shown to stimulate the proliferation of both ovine and bovine GCs, while not 
stimulating rat GCs, suggesting that the GCs of different species interact with BMP15 in a 
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species-specific manner (McNatty et al., 2005a, 2005b). Ovine BMP15 and GDF9 combined 
were shown to have a synergistic effect in sheep, however in cows both proteins combined 
were no different at stimulating GC proliferation than ovine BMP15 alone (McNatty et al., 
2005a). In another study using mouse follicles, BMP15 or GDF9 alone was shown to 
promote pre-antral follicle growth in vitro during the first 24 hours of culture (Fenwick et 
al., 2013). However, between 48 and 72 hours of culture, the addition of BMP15 alone was 
found to cause follicle shrinkage and atresia as well as increased apoptosis of granulosa 
cells. Interestingly, when GDF9 was added alongside BMP15, the shrinkage and atresia 
effects were eliminated, even with culture beyond 24 hours, and instead there was 
increased growth beyond what was seen with the addition either protein alone (Fenwick 
et al., 2013). An ALK6 inhibitor blocked the effects of BMP15 while an ALK5 inhibitor 
blocked the effects of both GDF9 and the combined effects of GDF9 with BMP15 (Fenwick 
et al., 2013).  
 
1.2.5.3 In vivo Bioassays 
 
Ewes immunized long-term against peptides specific to either BMP15 or GDF9 tended to 
show anovulation and abnormal follicle development, supporting the hypothesis that both 
proteins are essential for healthy follicle development in mono-ovulatory mammals 
(Juengel et al., 2002). Moreover, it was later found that short-term immunisation against 
BMP15 or GDF9 specific peptides increased the ovulation rate in immunized ewes (Juengel 
et al., 2004). It was also shown that immunisation at different regions of the mature peptide 
for each protein had different fertility outcomes, whereby immunization against the N 
terminal region tended to induce anovulation whereas immunization against the central 
portion could increase ovulation rate (McNatty et al., 2007). A similar immunization study 
carried out in cattle demonstrated the importance of both proteins in follicle development 
and ovulation, however the immunisations were less effective than in sheep, possibly 
highlighting differences in the roles of each protein between species (Juengel et al., 2009).  
Similar immunization approaches against the proregion of BMP15 in mice caused fewer 
corpora lutea to form in the ovaries and smaller litter sizes, while immunisation against 
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GDF9 caused more corpora lutea to form, and a substantial drop in litter size (McIntosh et 
al., 2012). These results suggest that the proregions of BMP15 and GDF9 are important in 
mouse fertility outcomes. Transgenic mice which were created to overexpress mature 
human BMP15 in the oocytes were found to have accelerated follicle growth, an increase 
in the proliferation of granulosa cells, a decrease in granulosa cell FSH receptor mRNA 
expression, and an early decline in ovarian follicle reserve (McMahon et al., 2008a). The 
findings of the study suggest BMP15 promotes follicle growth while preventing follicle 
maturation in mice, which may be why BMP15 is found in such low levels in polyovulatory 
species such as mice (McMahon et al., 2008a).  
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1.3 Significance of the Study 
 
The number of offspring produced in a single litter varies significantly between different 
mammalian species. The litter size is dependent upon the number of eggs released during 
ovulation and the developmental competence of each oocyte. BMP15 has been shown to 
influence ovulation rate as well as developmental competency of the oocyte by regulating 
granulosa and cumulus cell function during development, including through interactions 
with the closely-related GDF9 protein (Paulini and Melo, 2011). It has been almost two 
decades since BMP15 was first discovered, and in that time a vast number of studies across 
a range of different mammalian species have corroborated the idea that BMP15 is a key 
factor in determining fertility outcomes through roles that are specific to each species 
(Persani et al., 2014). Further research into the mechanisms behind follicular development 
and fertility is important for improving our understanding of the causes behind a range of 
fertility disorders, and may eventually lead to potential therapeutic options that target the 
pathways involved (Persani et al., 2014). Furthermore, an improved understanding may 
also be useful in improving the success rate of assisted reproductive technologies such as 
IVF and IVM, which currently have highly variable and often unsuccessful outcomes 
(Gilchrist, 2011; Mottershead et al., 2015; Persani et al., 2014).    
Whilst a substantive body of research has been collected over the past decade on BMP15, 
its actions on, and molecular forms in, different species with a range of litter sizes are 
unknown. Almost all of the current research into its molecular forms has involved the use 
of recombinant proteins, rather than investigating the native forms. Knowledge of the 
native forms could provide more accurate information on species specific-differences in 
molecular forms, and the relative amounts of each form of the protein produced in a more 
natural setting. One study has looked at the molecular forms of rat and sheep BMP15 in 
oocyte lysate and oocyte conditioned media (Lin et al., 2012). This current study aims to 
corroborate what has been reported previously regarding the forms of BMP15 in rats and 
sheep, as well as investigate the molecular forms and relative amounts of BMP15 in two 
new species, namely pigs and red deer. Pigs are of particular interest because they are a 
non-rodent species with a high litter size. Moreover, the pig is the only species studied 
which does not match the trend whereby a high ratio of GDF9:BMP15 relates to a large 
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litter size (Crawford and McNatty, 2012). In pigs, the ratio of GDF:BMP15 mRNA produced 
is a relatively low 0.51, despite having a large litter size of 14-22 offspring (Crawford and 
McNatty, 2012). Information on the native molecular forms of BMP15 may provide clues 
as to why this is. The red deer is a strict monovulator, more so than the sheep, and will 
provide a good comparison for the pig. Furthermore, comparisons of the native molecular 
forms with previously published information on the recombinant molecular forms will 
provide insight into the accuracy of the use of recombinant forms as models of the proteins 
in a native setting.   
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1.4 Aims   
 
Aim 1:  To characterise and optimise a novel monoclonal antibody (Mab61B) for detecting 
the different molecular forms of BMP15 across different mammalian species, and 
to compare these results with a previously-characterised monoclonal antibody 
(Mab61A) that has proven effectiveness both in recognising different molecular 
forms, and in providing immunosuppression of native forms of BMP15. 
To address this aim, Western blots were performed with the Mab61B monoclonal 
antibody under various conditions using both recombinant and native forms of 
BMP15 from a range of mammalian species until optimal signal was obtained. The 
protein forms detected under optimal conditions were then compared to those 
which could be detected by the fully-characterised Mab61A antibody in order to 
determine which antibody would be best for use in this study. 
Aim 2:  To determine the native molecular forms of BMP15 that were present both in the 
oocyte (intra-oocyte) and secreted from the oocyte (oocyte-secreted) in a range of 
different mammalian species with different litter sizes. 
To address this aim, Western blots were performed using oocyte lysates and 
oocyte-conditioned media from pigs, red deer, rats and sheep, which have litter 
sizes of 14-22, 1, 7-16 and 1-3, respectively. Western blots were performed under 
non-reducing and reducing conditions, and included cross-linked forms under 
reducing conditions to provide insight into the forms that exist and the strength 
of any potential dimer or multimer formations. These blots were then stripped 
and probed with an antibody targeting GDF9 to determine if any of the molecular 
forms detected with the anti-BMP15 antibody were in a complex with the highly 
homologous GDF9 protein.  
Aim 3:   To determine the differences in the relative amounts of each of the molecular forms 
of BMP15 present, both within and between species. 
To address this aim, densitometric analysis was performed on the bands that 
represented the different forms of BMP15 detected in the Western blots. The 
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relative amounts of the different forms between species were normalised to 
either the amount of a constitutively-active reference protein (β–actin), or to the 
number of oocytes used for each species to elucidate the best normalisation 
procedure. Finally, to account for inter-blot variation when the blots were 
normalised to the number of oocytes, the different molecular forms within each 
blot were also normalised against the positive control (recombinant pig mature 
BMP15 band) present in each blot. 
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Chapter 2: Materials and General Methodology 
 
2.1 Methods 
 
2.1.1 Ovary Collection 
 
Rat ovaries were collected from prepubertal Sprague-Dawley rats aged between 3 and 4 
weeks. The rats were sacrificed by asphyxiation with CO2 gas followed by cervical 
dislocation which was a standard operating procedure that had been approved by the VUW 
animal ethics committee. The ovaries were removed and placed into in a 15 mL centrifuge 
tube containing M199 collection media (Sigma-Aldrich) at room temperature. Once all 
ovaries had been collected, they were taken a short distance to the lab and transferred to 
a 30mm petri dish with fresh M199 collection media. Excess connective tissue surrounding 
the ovary was then carefully removed under the Leica MZ9S stereo microscope using 
dissection scissors. 
 
Sheep ovaries were collected from lambs and ewes of unknown background from the 
Taylor Preston meat processing plant in Ngauranga, Wellington. The ovaries were 
transported back to the laboratory on ice. Excess tissue was then trimmed from each ovary, 
and they were washed for 10 seconds in 70% ethanol to remove any potential bacterial 
contamination before being thoroughly rinsed with 0.9% saline solution. The ovaries were 
kept in 0.9% saline solution at room temperature before being transferred to M199 
collection media in a 100mm petri dish for oocyte collection. 
 
Deer ovaries were collected from red deer of unknown background from the Venison 
Packers Feilding Ltd meat processing plant in Fielding. The ovaries were washed with 0.9% 
saline before being placed in fresh 0.9% saline in a vacuum flask and transported for 3 hours 
back to the laboratory.  
 
Pig ovaries were collected from farmed pigs of unknown background from the production 
line at Cabernet Foods, Kintyre Meats Ltd in Gladstone. The ovaries were washed (as 
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described above for the deer ovaries) and transported for 2 hours back to the laboratory. 
Back in the laboratory, the deer and pig ovaries were trimmed and washed, before being 
transferred to M199 collection media in a 100mm petri dish for oocyte collection. 
 
Ovaries from each species were collected throughout the year between April and October. 
Ovaries with obvious Corpora lutea were not used for oocyte collection. Oocyte samples 
were collected across multiple days and the samples from each species used for each 
experiment were selected at random. 
 
2.1.2 Oocyte collection  
 
To collect oocytes from rats, rat ovaries were placed in a 60mm petri dish containing M199 
collection media under a dissecting microscope. The ovaries were punctured repeatedly 
with a 26G precision glide needle until it appeared that all of the follicles had been 
ruptured. The ovary was then discarded. A maximum of five ovaries were processed per 
dish. The media containing the ovaries was then very slowly pulled through a 20G needle 
into a 5 mL syringe before being injected very gently into a 40μm cell strainer. The oocytes 
were then carefully washed off the cell strainer into a new 30mm petri dish by inverting 
the strainer and injecting fresh M199 collection media through it. Once the cells had been 
allowed to settle, rat cumulus cell-oocyte complexes (COCs) and denuded oocytes (oocytes 
free of any cumulus cells) were collected and transferred to another 30mm petri dish with 
fresh M199 collection media using a 10μL Gilson pipette.  
 
Once all COCs and denuded oocytes were collected, the fully denuded oocytes were 
transferred into 1.5 mL microcentrifuge tubes containing fresh M199 collection media in 
aliquots depending on the number of oocytes required (200 for oocyte lysate samples and 
250 for oocyte-secreted media). The remaining COCs were then gently drawn into a 5 mL 
syringe via a 20G needle and reinjected back into the petri dish several times to detach the 
cumulus cells. Once fully or partially denuded, the oocytes were transferred into the 1.5 
mL microcentrifuge tubes. Partially denuded oocytes were accepted as it was difficult to 
remove the last few cumulus cells (<10) without damaging the oocyte.  Only healthy 
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oocytes, as assessed by morphology, with an intact cell membrane were transferred.  Once 
all oocytes were transferred, the microcentrifuge tubes were centrifuged at 500g for 4 
minutes at room temperature. The supernatant was carefully discarded using a pipette 
under a dissecting microscope, and the oocytes were then resuspended in fresh M199 
collection media. The tubes were once again centrifuged at 500g for 4 minutes and then 
the supernatant removed. At this stage, the oocytes intended for use as a lysate sample 
had 1μL of 10X protease inhibitor solution added and were vortexed vigorously before 
being centrifuged for 1 minute at 7000g. The oocyte lysate samples were then snap-frozen 
by placing the tubes in dry ice, and the tubes were stored at -80°C until required. The 
oocytes that were intended for incubation to provide the oocyte-secreted media samples 
were resuspended in 25μL of M199 incubation media and placed in an incubator at 37°C 
(5% CO2, 95% humidity) for 18 hours. Following incubation, the tubes were centrifuged at 
500g for 4min and the conditioned media (media containing the native BMP15 secreted 
from the oocytes) was transferred to a new 1.5 mL microcentrifuge tube, carefully avoiding 
the transfer of any cells. The incubated oocytes used to provide the secreted media were 
discarded and not used in subsequent experiments. An aliquot of 2.5μL of 10X protease 
inhibitor solution was added to the conditioned media and it was stored at -80°C until 
required. 
 
Sheep and deer oocytes were collected by first placing the ovaries in a 600mm petri dish 
partially-filled with M199 collection media and then slicing them in half through the hilum 
along the midline. A maximum of two ovaries were processed per petri dish. The halves of 
each ovary were punctured using a 20G needle fixed to a 5 mL syringe until all healthy 
follicles were ruptured. The fully-punctured ovaries were then discarded. Once oocytes had 
been removed from all ovary halves, the media was gently drawn into the 5 mL syringe via 
the 20G needle and then reinjected into the petri dish several times to partially denude the 
oocytes and break up any other cell debris present. The media was once again drawn into 
the syringe and then gently injected into a 100μM cell strainer. The cells collected in the 
cell strainer were washed off into a new 60mm petri dish using fresh M199 collection 
media. The COCs and denuded oocytes were then transferred to fresh media in a 30mm 
petri dish using a 10μL Gilson pipette. The fully denuded oocytes were then transferred 
into microcentrifuge tubes containing fresh M199 collection media. The remaining COCs 
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were fully or partially denuded using a syringe in the same manner as the rat oocytes before 
being transferred to the microcentrifuge tubes. Final aliquots for the sheep oocytes were 
either 100 oocytes per tube for the oocyte lysate samples, or 125 oocytes per tube for the 
oocyte-secreted media samples. The oocyte aliquots were washed and then either frozen 
or incubated using the method previously described above. However, one modification was 
that the temperature used to incubate the ovaries was 39°C, rather than 37°C, to more 
closely resemble the body temperature of sheep and deer. All samples were stored at -80°C 
until required. 
 
Pig oocytes were collected in a very similar manner to sheep and deer oocytes; however 
there were a few points of difference. The ovaries were not sliced in half prior to being 
punctured with a needle as the abundance of follicles rendered it unnecessary, and a 70μM 
strainer was used rather than a 100μM strainer due to the smaller oocyte size. The oocytes 
were collected in aliquots of 80 oocytes for the cell lysate samples, and 100 oocytes for the 
incubation samples. Also, the physical denudation stage using the syringe was not required 
as the pig oocytes tended to leave the follicles in a fully denuded state when they were 
punctured.    
 
2.1.3 Western blotting 
 
2.1.3.1 Preparation of SDS-PAGE gel 
 
The polyacrylamide separating gels were made using either 13.5%, 15% or 7.5% (v/v) 
acrylamide/bis solution, and each separating gel was combined with a 4% acrylamide 
stacking gel (see Table 2.1). The gels were prepared using 0.75mm Mini-PROTEAN casting 
module (Bio-Rad Laboratories, Cat#1658008) as part of the Mini-Protean Tetra Cell 
electrophoresis kit (Bio-Rad Laboratories, Cat# 165-8000). The reagents in the separating 
gel at the desired acrylamide percentage (Table 2.1) were combined in a glass beaker 
before being added to the glass casts secured on the casting module. A thin layer of High-
Q water was added to the top of the separating gel mixture in each cast to prevent the gel 
from drying during polymerisation. The gel was then left for at least 1 hour at room 
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temperature to polymerise. Once polymerisation was complete, the thin water layer was 
removed and the 4% stacking gel solution was carefully added on top of the separating gel. 
At this stage, a 0.75mm gel comb (10 or 15 wells depending experiment) was inserted into 
the stacking gel solution, and the stacking gel was left at room temperature for a further 
~30 minutes to polymerise. Once the stacking gel was polymerised, the comb was either 
removed, and the gel used immediately, or the comb was left in place and the gels were 
stored at 4°C in a sealed plastic back covered in wet paper towels for future use.  
 
Table 2.1: Separating and stacking gel recipes (makes two separating and 4 stacking gels) 
Reagents 15% 
Separating gel 
13.5% 
Separating gel 
7.5% 
Separating gel 
4% 
Stacking gel 
High-Q distilled water 2.35 mL 2.85 mL 4.85 mL 3.0 mL 
1.5M Tris-HCl pH8.8 2.5 mL 2.5 mL 2.5 mL 0 mL 
0.5M Tris-HCl pH6.8 0 mL 0 mL 0 mL 1.25 mL 
Bis-acrylamide mix 
(30%) 
5.0 mL 4.5 mL 2.5 mL 0.65 mL 
10% (w/v) SDS 0.1 mL 0.1 mL 0.1 mL 50 μL 
10% (w/v) ammonium 
persulphate 
50 μL 50 μL 50 μL 25 μL 
TEMED 5 μL 5 μL 5 μL 5 μL 
 
 
2.1.3.2 Sample Preparation 
 
Samples required for each gel were thawed, vortexed well and then centrifuged briefly for 
removal of cellular debris. In order to keep the sample volume constant between wells for 
a given blot, additional M199 incubation media was added to as required to those samples 
with less volume such that they matched the highest sample volume for the blot. At this 
stage, if a given sample type was to be compared across several blots under different 
conditions, such as an oocyte lysate sample under reducing and non-reducing conditions; 
the samples were combined in one microcentrifuge tube, vortexed briefly, and then re-
separated into individual tubes to ensure that the sample was homogeneous between 
blots. Next, if a sample was required to be crosslinked, freshly prepared 14mM (7X-
strength) BS3 crosslinking solution was added to give a final concentration of 2mM in the 
sample, and the sample was vortexed briefly before being left at room temperature for 30 
minutes to allow the non-cleavable crosslinking reaction to occur. Double-strength 
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modified Laemmli loading buffer (either reducing or non-reducing, see Appendix I; Table 3) 
was then added to each sample in a 1:1 ratio and the samples were denatured in a water 
bath at 95°C for 5 minutes. Unless it is stated that a non-reducing loading buffer was used, 
it can be assumed that a reducing loading buffer was used. The samples were then 
centrifuged at 1000g for 2 minutes using a Minispin Plus centrifuge to remove any insoluble 
particles, and loaded onto the gel. Different ladders were used in different gels depending 
on the protein of interest and availability. The SDS-PAGE broad range ladder (Bio-Rad) was 
combined with an equal volume of double-strength modified Laemmli reducing loading 
buffer (see Appendix I; Table 3) and denatured in a water bath at 95°C for 5 minutes. Where 
the Kaleidoscope prestained SDS-PAGE standards and the Precision Plus Protein Dual Color 
standards (Bio-Rad) were used, these reagents were utilised at room temperature without 
heating or the addition of a loading buffer as per the manufacturer’s directions.  
 
2.1.3.3 Gel Electrophoresis and Transfer 
 
The gels were placed in a Mini-Protean Tetra Cell running cassette (Bio-Rad Laboratories, 
Cat# 165-8000) and secured in place. When an odd number of gels were being run, a buffer 
dam (Bio-Rad Laboratories, Cat# 165-3130) was used. The cell was filled with running buffer 
(5x running buffer diluted to 1X with High-Q water, see Appendix I, Table 3) according to 
the manufacturer’s directions, and the gels were electrophoresed for 1-1.5 hours at 150V 
until the loading dye had run out of the bottom of the gel.  
 
The protein in the gels was then transferred to nitrocellulose membranes (Amersham 
Protran, GE Healthcare, Cat# 10600004) using a CriterionTM Blotter with plate electrodes 
(Bio-Rad Laboratories, Cat# 170-4070).  To prepare the transfer cassette for protein 
transfer, a gel/blot assembly tray was filled with transfer buffer (see Appendix I, Table 3). 
Four pieces of gel blotting paper and one piece of nitrocellulose membrane were trimmed 
to approximately 10cmx7.5cm per each gel to be transferred. The blotting paper, 
nitrocellulose membrane and two foam pads were soaked in transfer buffer and stacked 
within the transfer cassette in the following order from top to bottom: 
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Top 
Red side of cassette (positive charge) 
Foam pad 
2 pieces of blotting paper 
Membrane 
Gel (removed from glass cast and stacking gel discarded) 
2 pieces of blotting paper 
Foam pad 
Black side of cassette (negative charge) 
Bottom 
 
As each layer was added, a roller was used to remove any air bubbles, and tweezers were 
used when handling the membrane to avoid any contamination. Care was taken to ensure 
the membrane did not move once in contact with the gel. The assembled cassette was 
clasped together and then placed into the Criterion Blotter along with and ice pack (frozen 
at -20°C) and a magnetic stir bar. It was then filled with transfer buffer (stored at 4°C) until 
the cassette was submerged, and then the whole device was placed in an ice bath over a 
magnetic stirrer. The transfer was then carried out for 1 hour at 100 V. Once the transfer 
was complete, the membrane was removed from the cassette and the gel carefully 
separated from the membrane and discarded. The membrane was then trimmed to the gel 
area, and the ladder was lightly marked with a pencil. The membranes were stained with 
Ponceau S stain (see Appendix I, Table 3) for 1 minute, and then rinsed briefly with distilled 
water until the protein bands were visible to demonstrate a successful transfer. If the lanes 
on the membrane were to be divided for multiple antibody incubations, this was done at 
this point. The Ponceau S stain was then fully removed from the membrane by washing 
with membrane wash buffer (see Appendix I, Table 3) for 2 x 10 minutes on a see-saw 
rocker set at 15 tilts/min. The membrane was then placed in a plastic container (Uniware, 
see Appendix I, Table 1) and incubated for 1 hour in blocking buffer under agitation via a 
low speed Orbit LS shaker set at 60rpm at room temperature. The blocking buffer used 
contained 5% skim milk powder unless stated otherwise (see Appendix I Table 3).  
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2.1.3.4 Immunodetection of target proteins 
 
Once incubation with the block buffer was complete, the buffer was discarded and the 
primary antibody solution was added to each membrane. Different primary antibodies 
were used for different experiments; however every antibody used was diluted in blocking 
buffer to make the primary antibody solution. Mab61A (anti-BMP15) and Mab37A (anti-
GDF9) were used at 1 µg/ml in all experiments while Mab61B (Anti-BMP15) was used at 
either 1 µg/ml or 2 µg/ml (see Appendix I, Table 4 for antibody details). The mouse 
monoclonal β-Actin primary antibody (Sigma-Aldrich, cat# A5441) was used at a 1:5000 
dilution. The membrane was incubated for 12 hours in primary antibody solution at 4°C on 
a low speed Orbit LS shaker set at 60rpm unless stated otherwise. Thereafter, the 
membrane was washed 3 x 10 minutes with membrane wash buffer (see Appendix I, Table 
3) on a see-saw rocker set at 15 tilts/min. Following the wash step, the membranes were 
incubated with the secondary antibody solution (Peroxidase-conjugated Affinipure Rabbit 
Anti-mouse IgG, Jackson ImmunoResearch Laboratories Inc). Unless stated otherwise, the 
secondary antibody was diluted 1:2000 in blocking buffer to a final concentration of 0.2 
µg/mL. The membrane was incubated for 2-5 hours (depending on the experiment) at room 
temperature on a low speed Orbit LS shaker set at 60rpm. In the case of blots using oocyte 
lysates and conditioned media, a 5 hour incubation time was used. The membrane was 
then washed 3 x 10 minutes with membrane wash buffer (Appendix I, Table 3) on a see-
saw rocker set at 15 tilts/min. The membrane wash buffer was then discarded before 
immediately proceeding with chemiluminescent detection. If chemiluminescent detection 
could not be immediately performed, for instance if multiple blots needed to be imaged 
separately, then the blots were kept in membrane wash buffer at 4°C for up to 2 hours 
before proceeding with the protein detection to prevent the membrane from drying out. 
 
2.1.3.5 Chemiluminescent Detection 
 
Chemiluminescent detection was used to visualise the labelled proteins on the membrane. 
First, all membrane wash buffer was poured off the membrane and the membrane was 
sprayed 3 to 4 times with the WesternBright ECL-Spray (Western Blotting Detection 
System; Advansta). Once sprayed, the membrane was gently rocked from side to side for 2 
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minutes before removing the membrane from the spray solution with tweezers, and 
allowing the majority of the spray to drip off, before placing the membrane on a piece of 
3M transparency film. The membrane and transparency film were then placed inside an 
Omega Lum G Imaging System (Aplegen). The membranes were imaged using the Chemi 
HD settings at various exposure times and cumulative exposures depending on the 
experiment. If a given blot was going to be directly compared with other blots, the exposure 
length was kept constant. The oocyte lysate and oocyte-conditioned media blots for each 
species under non-reducing, reducing and crosslinking conditions were all exposed for 
1x10min to ensure full comparisons could be made. The number of exposures and the 
exposure length used was chosen to provide the strongest possible signal of all bands 
present without any of the bands being saturated. In some cases, multiple different 
exposures were taken from the same blot so that results were available at optimal 
exposure lengths for both the dense and the faint bands on the same blot.  
 
All images from the blots were saved in their raw TIFF file format. This was used for 
densitometric analysis. Images were also saved in JPEG format so that if visual comparisons 
were made between the images of different blots, the black, white and gamma levels could 
be kept constant. Once all the required chemi HD images had been saved, the same 
membranes were then imaged using the epiwhite setting on the Omega Lum G imaging 
system, with the exposure set to automatic. This image was saved as a JPEG format and 
was used to visualise the ladder which had been marked with pencil earlier in the process, 
and was later used to add the ladder to the corresponding chemi HD chemiluminescent 
images. The membranes which were required for further experiments were then placed in 
a fresh plastic container (Uniware) and were washed for 2x10min with membrane wash 
buffer before proceeding to the membrane stripping protocol for antibody removal. 
Membranes not required for future experiments were discarded. 
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2.1.3.6 Membrane Stripping 
 
A stripping buffer was prepared in a Duran glass bottle (see Appendix I, Table 3) and pre-
heated to 50°C in a water bath. The membranes to be stripped were placed in 200 mL 
sealable Klip ItTM containers (Sistema) and sufficient membrane stripping buffer was added 
to provide approximately 1cm of cover over the entire membrane. This was then placed in 
the 50°C water bath for 30minutes, with gentle agitation every 5 minutes. The stripping 
buffer was then discarded from the container, and the membrane was washed 3 x 10 
minutes with large volumes of membrane wash buffer. The membrane was then blocked 
for 1 hour in blocking buffer containing 5% (w/v) skim milk powder unless stated otherwise. 
Immunodetection and chemiluminescent detection was then performed as in Sections 
2.1.3.4 and 2.1.3.5. 
 
2.1.3.7 Antibody preadsorption 
 
Primary antibody solutions of both Mab61A and Mab61B for preadsorption were prepared 
24 hours prior to use. The primary antibody concentrations have been previously described 
(see Section 2.1.3.4). The blocking peptide (either Peptide B, E.coli-produced ovine BMP15 
or E.coli-produced ovine GDF9) was incubated with the primary antibody at a ratio of either 
25:1, 3:1 or 10:1 by mass (indicated by relevant figures) in 200μL of membrane wash buffer 
in a 1.5 mL microcentrifuge tube. The blocking-peptide to antibody ratio by mass stated for 
each figure (stated as w/w) represents the ratio between the total mass of the blocking 
peptide and the total mass of the antibody present. The tubes were placed on a Vibrax VXR 
Basic vibrating stirrer (IKA) set to low speed and incubated 24 hours at 4°C. Following 
incubation, the tubes were centrifuged at 600g for 5 minutes on a Minispin Plus centrifuge 
(Eppendorf) and the supernatant was added to the membrane in a final volume of 6μL of 
blocking buffer. Immunodetection and chemiluminescent detection of these blots has been 
previously described (see Sections 2.1.3.4 and 2.1.3.5, respectively). In experiments where 
a preadsorbed antibody was to be compared to a non-preadsorbed antibody, the non-
preadsorbed antibody was subject to the same conditions as the preasdorbed antibody. 
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2.1.4 Calculation of band size 
 
The molecular weights of the bands were determined by first calculating the Rf of each 
band using the protein ladder as guidance (where Rf = the distance migrated of the protein 
/ the distance migrated by the dye front for the resolving portion of each gel). The Rf values 
were then plotted on the x axis against the log10(molecular weight) of each band on the y 
axis. A linear regression was fitted to the points and the formula of the resultant regression 
line was calculated. The Rf values of the chemiluminescent labelled proteins was then 
measured and the formula of the linear regression line was used to convert the Rf values 
to their respective molecular weight values for each band. When a band size varied slightly 
across multiple blots, an approximate range for the band size is stated. 
 
2.1.5 Densitometric analysis 
 
Semi-quantitative analysis of the relative density of bands was performed using ImageJ 
software (version 1.50b with Java 1.8.0_60 64-bit;  National Institutes of Health (NIH); 
Schneider et al., 2012). Raw TIFF format 16bit images of the bands taken by the Omega 
Lum G imaging system (Aplegen) (see Section 2.1.3.5) were transferred to a PC for analysis. 
The images were first checked for saturation using Image Studio Lite version 5.2 (Li-COR 
Biosciences) and only images taken at exposures where no saturation was detected in all 
bands were used for analysis. The image to be quantified was loaded into Image J software. 
The mean grey value was set as the only measurement category, and image type was set 
to 16 bit. The rectangle selection tool was used to create a frame around the largest band 
to be analysed and this rectangular selection frame was saved and subsequently used for 
all bands analysed. The rectangular selection frame was placed over each band to be 
analysed, and the mean grey value was calculated. The mean grey value was represented 
by a value between 0 and 65,536 due to the 65,536 possible shades of grey for each pixel 
in a 16 bit image. The higher the number, the greater the density of the band, with a value 
of 65,536 representing a selection box which was filled completely with black pixels, and 
any lower numbers representing the mean of the shade value of the pixels within the 
selection box. Within each blot, the selection frame was moved to three separate points 
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where there were no bands and the mean grey value was calculated. The average of these 
three values was deemed to be the background, and this was subtracted from the mean 
grey values of each band on that blot to give the final density value for each band which 
was used for future analysis. 
 
2.1.6 Graphs and Statistical Analysis 
 
Densitometry data was graphed and analysed using Prism Software (version 6.01; 
Graphpad). Density values were presented either relative to β-actin, or to the number of 
oocytes present in each sample. Linear regressions were fitted to densitometry data, and 
statistical analysis of the slopes was performed using Prism Software Version 6.01 
(Graphpad) where applicable.  
 
When the values were presented relative to β-actin, the density of the BMP15 bands were 
measured, and then the blots were stripped and relabelled with an anti-β-actin antibody. 
The BMP15 values for a given blot were presented relative to the density of the β-actin 
band found in the oocyte lysate of the same blot. As β-actin was only present in the oocyte 
lysate sample of each blot, the BMP15 band density values measured in the oocyte 
conditioned media was presented relative to 1.25X the density of the β-actin band found 
in the oocyte lysate of the same blot. A multiple of 1.25 was used to adjust for the fact that 
25% more oocytes were used in the oocyte conditioned media samples.  
 
When the values were presented relative to the number of oocytes, the density of the 
BMP15 bands in the oocyte samples were adjusted by dividing the band density values by 
a factor determined by the number of oocytes in the sample/100. For example, in rat 
oocyte lysate samples where 200 oocytes were used, the density values were divided by 2 
(200/100=2). These oocyte-count adjusted values were then normalised against the 
recombinant pig mature BMP15 band in the positive control to account for inter-blot 
variation. To do this, the adjusted density value for a band on a given blot was divided by 
the density of the mature band in the recombinant HEK-293 produced pig BMP15 positive 
control on the same blot. 
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When comparisons were made within a given species, such as between the promature and 
mature BMP15 band densities, or between the promature:mature ratios of the oocyte 
lysates and oocyte conditioned media samples, a  Student’s t-test was performed to 
determine if there was a significant difference between the groups. When comparisons 
were made across all four species, a one-way ANOVA with Bonferroni’s post-hoc test was 
performed. In all comparisons, P ≤ 0.05 was considered significant. When band density 
values were presented relative to the density of another band, such as when the BMP15 
band densities were presented relative to the β-actin band densities, the ratios were 
calculated within each replicate first, and then the mean of the ratios from the three 
replicates was calculated. 
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Chapter 3: Results 
3.1 The monoclonal antibody Mab61B has a significantly 
reduced ability to detect promature BMP15, and a 
moderately reduced ability to detect mature BMP15 on a 
Western blot, compared to Mab61A 
 
The first aim of this study was to characterise a novel monoclonal antibody provided in-
house (Mab61B) that had been generated against a 14 amino acid sequence at the N-
terminus of mature ovine BMP15, and compare it to a previously characterised antibody 
(Mab61A; Lin et al., 2012) (see Appendix II for details on the antibodies). Mab61B was first 
used to detect recombinant sheep, pig and deer BMP15 on a Western blot under the 
originally optimal conditions for Mab61A (Figure 3.1 A). Under these conditions, Mab61B 
showed a moderate ability to pick up mature BMP15 from all three species (band between 
~11-14 kDa); however it lacked the ability to detect promature BMP15. Instead, two faint 
bands were detected in the ~55-70 kDa range which were also detected in the negative 
controls.  Under the same conditions, Mab61A showed a good sensitivity for both the 
BMP15 mature (~11-14 kDa band) and promature BMP15 (~47-50 kDa band) protein in 
each species tested, with a particularly strong pig BMP15 promature band detected (Figure 
3.1 C). Mab61A also detected two distinct unknown bands in the ~60-75 kDa range which 
were also found in the negative controls.  
 
To determine whether the lack of promature BMP15 detection with Mab61B was due to a 
lack of sensitivity caused by the Western blotting protocol being used, a range of 
optimisation tests were undertaken (Figure 3.1 E). Under the optimised conditions, 
Mab61B had an increased ability to detect the mature BMP15 protein, which was coupled 
with a large increase in the density of the two non-specific bands detected in the ~55-70 
kDa range, and still no detection of the promature BMP15 protein (Figure 3.1 B), despite 
Mab61A demonstrating that it was present in the samples (Figure 3.1 C). To test whether 
the detection of promature BMP15 with Mab61B was dependent on the amount of protein 
loaded on the gel, a titration of recombinant pig BMP15 conditioned media was performed 
and protein detection was measured using Mab61B under optimal conditions (Figure 3.1 
 
 
39 
 
D). Even when an excessive amount (8L) of the pig BMP15 sample was loaded onto the 
gel, there were no obvious bands detected at the expected promature BMP15 size.    
 
The following experiment tested whether Mab61B could detect the native promature and 
mature forms of BMP15 in oocyte lysate samples (Figure 3.2 A). The antibody was able to 
detect mature BMP15 in the oocyte lysate samples from sheep, pigs, deer and rats as 
indicated by the band at ~11-14 kDa in each species. Once again, there was no distinct 
promature band detected in any of the species tested, suggesting that Mab61B is unable 
to detect the promature BMP15 protein of any of the species tested in the context of a 
Western blot. The antibody Mab61B also detected a range of non-specific proteins 
between ~15 and 50 kDa, and a distinct protein at ~58kDa in size, which was a similar size 
to one of the non-specific bands observed in both the positive and negative controls. The 
blot depicted in Figure 3.2 A was then stripped of the Mab61B antibody, and reprobed with 
the Mab61A antibody to determine if promature BMP15 was present in the oocyte lysate 
samples, and to compare the sensitivity of Mab61A with Mab61B (Figure 3.2 B). The 
Mab61A antibody was able to detect mature BMP15 as a distinct band in the ~11-14 kDa 
range in the sheep, pig and deer oocyte lysate samples, but not in the rat oocyte lysate 
samples. The lack of a band at the known size of mature BMP15 in the rat oocyte lysate 
sample was attributed to a small amount of protein being further lost in the stripping 
process. The unavoidable loss of some protein during membrane stripping was established 
in earlier optimisation experiments of the stripping procedure (data not shown). In later 
experiments, it was determined that the Mab61A antibody detected mature rat BMP15 
with a similar affinity to the Mab61B antibody (data not shown). Unlike Mab61B, Mab61A 
was able to detect a large amount of promature BMP15 in sheep, pig and deer oocyte lysate 
samples, and a small amount in the rat samples as indicated by a distinct band in the ~47-
50 kDa range for each species (Figure 3.2 B). There were also several bands detected in the 
sheep, pig and deer oocyte lysate samples that were ~35-45 kDa in size, and did not fit the 
known size of the mature or promature proteins.   
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Figure 3.1: Mab61A showed a low affinity for recombinant promature BMP15 compared to Mab61A, 
even following an optimised Western blot protocol. (A) Western blot labelled with BMP15 antibody 
Mab61B using original Western blot conditions (conditions listed under “Original” in (E)) which were 
previously optimised in-house for the Mab61A antibody. The 1st, 3rd and 5th lanes depict 4μL of 
recombinant HEK-293-produced sheep, pig and deer BMP15 conditioned media, respectively. The 2nd, 
3rd and 6th lanes depict 4μL of recombinant HEK-293 produced sheep, pig and deer GDF9 conditioned 
media, respectively (negative controls). Lane 7 depicts 4μL of untransfected HEK-293 conditioned media 
(negative control). (B) Western blot of BMP15 labelled with Mab61B with same lanes as (A) performed 
under conditions optimised for Mab61B as outlined in the table of optimisations (E). (C) Western blot 
under same conditions as (A) except labelled with the Mab61A antibody. (D) Titrations of recombinant 
HEK-293-produced pig BMP15 and GDF9 conditioned media on a Western blot performed under 
optimised conditions as indicated by the table of optimisations (E) and labelled with Mab61B BMP15 
antibody. (E) Table of the different optimisation procedures tested for Western blotting. All blots were 
performed under reducing conditions. 
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Figure 3.2: Mab61B shows no affinity for the promature BMP15 protein in oocyte lysates, as compared 
to Mab61A. (A) Western blot labelled with Mab61B antibody. Lanes 1-3 were loaded with the lysate of 
100 sheep, pig and deer oocytes, respectively, and Lane 4 was loaded with the lysate of 200 rat oocytes. 
Lane 5 contained 4μL of recombinant HEK-293-produced pig BMP15 conditioned media (positive 
control). Lanes 6 and 7 were negative controls containing 4μL of recombinant HEK-293-produced pig 
GDF9 conditioned media, and 4μL of untransfected HEK-293 conditioned media, respectively. (B) The 
blot from (A) was stripped and reprobed with Mab61A (B). All blots were performed under reducing 
conditions. 
 
 
3.2 The monoclonal antibodies Mab61B and Mab61A have 
different non-specific binding targets, and different levels of 
specificity for their BMP15 target 
 
To determine the specificity of the bands detected by both the Mab61B and Mab61A 
BMP15 antibodies, a range of preabsorption experiments with different antigens were 
performed (Figure 3.3). Firstly, the peptide used to generate Mab61B in mice (Peptide B; 
see Appendix II) was used. Preabsorption of the Mab61B antibody with 25x w/w Peptide B 
lead to the loss of the band detected at ~11kDa (mature BMP15) in recombinant HEK-293-
produced pig BMP15. The unknown bands in the ~55-70 kDa size range were still detected 
with a similar affinity to those observed when using the non-preabsorbed Mab61B 
antibody (Figure 3.3 A). This suggests that the unknown bands in the ~55-70 kDa range 
were most likely due to high-affinity non-specific binding. The blot was then stripped and 
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re-probed with Mab61B antibody that had been preabsorbed with 10x (w/w) E.coli 
produced ovine GDF9 to test for cross reactivity with the closely related protein (Figure 3.3 
A). A band at the size of the mature BMP15 protein could still be detected when Mab61B 
was preabsorbed with GDF9, albeit at a slightly reduced density. This indicates that Mab61B 
exhibits minimal affinity for GDF9.  
In a separate experiment, Mab61B was preabsorbed with 10x (w/w) E.coli-produced ovine 
BMP15 (Figure 3.3 C). In this case, the mature band at ~11kDa disappeared, as did the 
55kDa band that represented one of the two unknown bands, however the higher 
molecular weight band at 70 kDa remained. Just like with the peptide B preabsorption, the 
presence of this band following preabsorption with BMP15 suggests that it may be due to 
high affinity non-specific binding of the antibody. The absence of the ~55kDa band suggests 
that this band is either due to specific binding of the antibody, or non-specific binding of 
the antibody to a protein that has significantly lower affinity than for the BMP15 used for 
preabsorption. The disappearance of the ~11 kDa band again supports the idea that this 
band represents mature BMP15 protein.  
The same experiments from Figures 3.3 A and C were repeated using the Mab61A antibody 
(Figures 3.3 B and 3.3 D). The Mab61A antibody was partially preabsorbed by peptide B, 
however it was still able to detect both promature BMP15 (~50 kDa band) and mature 
BMP15 (~11-14 kDa) (Figure 3.3 B). It is important to note that Peptide B contains only 8 of 
the 15 amino acids which Mab61A is known to target (see Appendix II), thus only partial 
absorption was expected. These results suggest that for effective binding, Mab61A relies 
on the presence of the remaining 7 amino acids of its known target region, which are not 
part of the peptide B sequence. The blot was then stripped and then re-probed with 
Mab61A which had been preabsorbed with E.coli-produced ovine GDF9 to test for cross 
reactivity (Figure 3.3 B). In this case the results were nearly identical to those seen using 
Mab61B in Figure 3.3 A, which suggests that Mab61A has minimal affinity to GDF9. The 
preabsorption of the Mab61A antibody with E.coli produced ovine BMP15 led to a 
complete loss of all bands on the blot, including the ~60-75 kDa bands of unknown protein 
(Figure 3.3 D). This suggests that either the antibody is binding to all bands on the blot 
specifically, or that the antibody is at least binding to the E.coli-produced ovine BMP15 with 
a higher affinity than other non-target proteins.  
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Overall, these results substantiate the general dogma that the bands at ~11 kDa and ~50 
kDa represent the mature and promature forms of BMP15, respectively. The bands in the 
~60-75 kDa size range were present in both the positive and negative controls and as such, 
are likely due to non-specific binding.    
 
 
Figure 3.3: Preabsorption of Mab61B and Mab61A antibodies differ with antigen, and exhibit 
divergent non-specific binding on Western blots. (A) Mab61B was preabsorbed with 25x w/w Peptide 
B. This blot was then stripped and reprobed with Mab61B preabsorbed with 10x w/w E.coli-produced 
ovine GDF9. The blot was then stripped a second time and re-probed with Mab61B without 
preabsorption. Lane 1 contains 4μL of recombinant HEK-293-produced pig BMP15 conditioned media 
(positive control). Lanes 2 and 3 are negative controls containing 4μL of untransfected HEK-293 
conditioned media, and 4μL of recombinant HEK-293-produced pig GDF9 conditioned media, 
respectively.  (B) The same Western blot layout in (A) was performed with Mab61A. (C) A Western blot 
with the same layout as (A) and (B) was probed with Mab61B which had been preabsorbed with 10x 
w/w E.coli-produced ovine BMP15. The blot was then stripped and re-probed with Mab61B without 
preabsorption. (D) The same set of experiments as described in (C) was performed with Mab61A. All 
blots were performed under reducing conditions. 
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3.3 High affinity non-specific bands in close proximity to 
specific target bands on Western blots may partially block 
the primary antibody from binding its specific target 
 
The Western blots immuno-labelled with Mab61B antibody in Figures 3.1, 3.2 and 3.3 
demonstrated that the antibody binds unknown non-specific bands in the ~55-75 kDa 
region with high affinity. These unknown bands were in close proximity to the target 
BMP15 promature band, unlike the unknown bands observed when using Mab61A (Figure 
3.1 B and C). To test whether the close proximity of the high affinity unknown proteins were 
blocking or masking the ability of Mab61B to bind its promature BMP15 target, a 7.5% 
acrylamide gel was used in place of a 13.5% acrylamide gel in order to provide a greater 
separation between the ~55-75 kDa bands, and the target BMP15 promature band at ~50 
kDa (Figure 3.4). For reference, Figure 3.4 A and B depicts the same results from the 13.5% 
gel in Figure 3.2 with just the region of interest displayed. The same region of interest from 
a 7.5% acrylamide gel is displayed in Figure 3.4 C and D. In this blot labelled with Mab61B 
(Figure 3.4 C), distinct bands appear in the ~48-50 kDa region which were not observed in 
the 13.5% gel (Figure 3.4A). These bands appear to correspond to the BMP15 promature 
bands observed when using the Mab61A antibody on the same blots after stripping (Figures 
3.4 B and D). This suggests that the unknown non-specific bands in the ~55-75 kDa region 
may have blocked Mab61B from binding to its promature BMP15 target in blots shown 
previously. It should be noted that with the exception of the rat, the BMP15 promature 
bands detected using Mab61B were much fainter than those detected with Mab61A after 
stripping, suggesting that the Mab61B antibody has a lower affinity for this protein.  
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Figure 3.4: Mab61B can bind promature BMP15 on Western blots when it is separated from non-target 
proteins of a similar size. (A) and (B) For reference, portions of Western blots made using 13.5% 
acrylamide gels from Figure 3.2 are shown. The blot in (A) was probed with Mab61B before being 
stripped and re-probed with Mab61A, shown in (B). The first 4 lanes are loaded with oocyte lysate from 
100 sheep, pig and deer oocytes, and 200 rat oocytes, respectively. Lane 5 was loaded with 4μL of 
recombinant HEK-293-produced pig BMP15 conditioned media (positive control), and Lanes 6 and 7 
were loaded with 4μL of recombinant HEK-293-produced pig GDF9 conditioned media, and 4μL of 
untransfected HEK-293 conditioned media, respectively (negative controls). (C) A portion of a blot with 
an identical lane structure to (A) made using a 7.5% acrylamide gel. The blot was labelled with Mab61B. 
(D) The blot in (C) was stripped and re-probed with Mab61A. All blots were performed under reducing 
conditions. 
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3.4 The optimal numbers of oocytes for detection of intra-
oocyte molecular forms of BMP15 in rats, sheep, pigs and 
deer are 200, 100, 80 and 100, respectively 
 
Due to the Mab61A antibody exhibiting a higher affinity and greater sensitivity towards 
BMP15, and also its ability to detect both mature and promature forms (as demonstrated 
in Figures 3.1-3.4), the Mab61A antibody was used for all future experiments. 
 
To determine the optimal number of oocytes required for detection of the molecular forms 
of BMP15 for each species, titrations of lysed oocytes were performed. For the rat, sheep, 
deer and pig, 200, 100, 100 and 50  lysed oocytes were sufficient for detecting both the 
promature (~50 kDa) and mature (~14-16 kDa) forms of BMP15 (Figure 3.5). However, in 
later experiments (data not shown), it was revealed that detection of the mature BMP15 
band was inconsistent when using only 50 lysed pig oocytes, and that 100 oocytes may 
have led to band saturation. Thus, an intermediate number of 80 lysed oocytes were used.  
 
Titrations were not performed to determine the number of oocytes to be used in the 
oocyte conditioned media samples. Instead, it was decided that the number of oocytes 
incubated per 25μL conditioned media sample would be 25% more than the number of 
oocytes used in the oocyte lysate samples. This 25% increase in number was chosen due to 
the amount of BMP15 secreted into the media by the oocytes in an 18 hour period being 
much lower than that in lysed oocytes. The increase in the number used was limited to 25% 
because it was observed that an increase in oocyte number of >25% caused a significant 
increase in the acidity of the media (as observed by colour change) during the 18 hour 
incubation period. This increased acidity may have affected the forms of the protein, and 
also compromised oocyte health. Given the higher levels of BMP15 present inside an 
oocyte compared to that secreted into the media, the rupture of a single unhealthy oocyte 
during incubation period could have significantly altered the results if its contents were 
released into the media. 
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Figure 3.5: Titrations of rat, sheep, deer and pig lysed oocyte numbers for the detection of BMP15 
using Mab61A. (A)(B)(C) Titrations of rat (A), sheep (B), and deer (C) oocyte lysates, respectively. The 
numbers above Lanes 1-4 represent the number of oocyte lysates used in that lane. Lane 5 contains 4μL 
of recombinant HEK-293-produced pig BMP15 conditioned media (positive control). Lanes 6 and 7 are 
negative controls containing 4μL of untransfected HEK-293 conditioned media and 4μL of recombinant 
HEK 293 produced pig GDF9 conditioned media, respectively. (D) Titrations of pig oocyte lysates. Lanes 
1-3 represent the number of oocyte lysates used in that lane. Lanes 4-6 contain the various positive 
controls in the same order as seen in Lanes 5-7 in (A), (B) and (C). All blots were performed under 
reducing conditions. 
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3.5 Estimation of the concentration of mature BMP15 in the 
recombinant HEK-293 produced pig BMP15 conditioned 
media 
 
Three replicate Western blot experiments were performed under reducing conditions to 
quantify the concentration of mature BMP15 in the HEK-293 produced recombinant pig 
BMP15 conditioned media used throughout this study. The result of one of the three 
replicates is presented in Figure 3.6. The purpose of this experiment was to give a 
contextual frame of reference as to the approximate amount of protein present when 
viewing blots. The approximate concentration of the mature BMP15 protein was estimated 
by blotting a titration of the recombinant HEK-293 produced pig BMP15 conditioned media 
(~12 kDa) alongside a titration of known quantities of E. coli produced mature ovine BMP15 
(~16-17 kDa) (Figure 3.6 A). The densities of these bands were plotted against the sample 
amount, and the values were fitted with a linear regression (Figures 3.6 B). The coefficients 
of determination (R2) for the conditioned media and E. coli produced BMP15 samples were 
at least 0.98 in all three replicates indicating a very strong linear correlation in both 
datasets. The mature BMP15 band that resulted from using 1 µL of the HEK-293 
conditioned media sample was not included in the linear correlation in any of the three 
replicates because its density fell outside the range detected in the E. coli produced 
samples. Each of the three replicates was graphed separately and the concentration of 
recombinant pig BMP15 in the HEK-293 conditioned media was estimated by comparing 
the densities of the three different HEK-293 conditioned media sample volumes with the 
standard curve generated using the E. coli produced BMP15 samples. The combined data 
from all three replicates estimated the concentration of recombinant pig BMP15 in the 
HEK-293 conditioned media to be 0.58 ng/µL (95% CI range of 0.55 to 0.61 ng/µL).   
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Figure 3.6: Estimation of the mature BMP15 concentration in the recombinant HEK-293 produced pig 
BMP15 conditioned media. (A) A Western blot performed under reducing conditions and labelled with 
Mab61A. Lanes 1 and 2 are negative controls containing 4μL of untransfected HEK-293 conditioned 
media and 4μL of recombinant HEK-293 produced pig GDF9 conditioned media, respectively. Lanes 3-6 
represent titrations of recombinant HEK-293 produced pig BMP15 conditioned media, with the volume 
of media per lane indicated above each lane (μL). Lanes 7-11 represent titrations of known quantities of 
E. coli produced ovine BMP15, with the amount of the protein present indicated above each lane (ng). 
There is a gap between Lanes 10 and 11 where no sample was loaded. (B) Scatterplot of the densities 
of the mature BMP15 bands found in Lanes 3-11 of (A). The data in red represents the densities of the 
E. coli produced mature ovine BMP15 bands, and relates to the top x-axis. The data in blue represents 
the densities of the recombinant HEK-293 produced pig BMP15 and relates to the bottom x-axis. The 
equations for each linear correlation, along with their R2 value are indicated below the relevant keys. 
The data in (A) and (B) represents one of three replicates.  
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3.6 The molecular forms of BMP15 in, and secreted from, 
oocytes of rats (litter size 7-16) 
 
To detect the molecular forms of BMP15 present in, and secreted from, the oocyte in 
different mammalian species, a series of Western blots were performed under non-
reducing conditions, reducing conditions and finally conditions where the proteins were 
crosslinked before the addition of a reducing loading buffer. Representative Western blots 
under these conditions in which rat oocytes were used are displayed in Figure 3.7. A total 
of 200 rat oocytes were used per oocyte lysate lane and 250 rat oocytes were used to 
generate each sample of oocyte conditioned media. 
 
Faint bands representing promature and mature BMP15 were observed in the rat oocyte 
lysates under all three conditions tested (Figure 3.7 A1, B1 and C1). Under reducing 
conditions, with or without crosslinking (Figures 3.7 B1 and C1), low levels of both 
promature (double band at ~48-52 kDa) and mature BMP15 (band at ~15-16 kDa) were 
detected. The molecular weights differed slightly from those observed in the positive 
control of recombinant pig BMP15, which is likely due to slight species differences in the 
proteins (c.f. Figure 3.9). Promature and mature BMP15 also appeared in the non-reduced 
oocyte lysate samples, and exhibited slightly higher molecular weights (~55-58 kDa and 
~17kDa, respectively) to those observed under reducing conditions. This may be due to 
existing intramolecular disulphide bonds remaining intact in the non-reducing buffer, 
hindering the passage of the protein through the gel. 
 
In both the crosslinked samples under reducing conditions, and the non-reduced samples 
(Figures 3.7 C1 and A1, respectively), there were bands representing unknown proteins in 
the ~150-250 kDa region of the oocyte lysates samples that were consistent across 
replicates. A band was observed in the same region in the reducing blot (without 
crosslinking), however this band was absent in the other two replicates (Figure 3.7 B1). 
When taken together, these bands indicate the presence of large covalently or possibly 
non-covalently bound protein complexes containing multimers of different molecular 
forms of BMP15, possibly together with other proteins.  
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Under non-reducing conditions, there was a consistent very faint band observed at ~35 kDa 
in the oocyte lysate samples (Figure 3.7 A1). While the molecular weight of the band 
corresponds with a possible mature BMP15 homodimer, this is unlikely to be the case as 
the band was not detected in samples that had been crosslinked (Figure 3.7 C1). 
Furthermore, homodimers of BMP15 are believed to be non-covalently bound which 
means they should be dissociated under non-reducing conditions. There were also no 
consistent bands in the ~60-150 kDa region, and thus there was no clear evidence of 
homodimer (BMP15-BMP15) or heterodimer (BMP15- GDF9) formation involving mature 
or promature BMP15 proteins in rat oocytes. No BMP15 in any molecular form was 
detected in the oocyte conditioned media samples across all three conditions, even when 
the blots were overexposed (Figure 3.7).  
 
In the recombinant HEK-293 produced pig BMP15 conditioned media (positive control), 
both promature and mature BMP15 were detected under reducing conditions, with or 
without crosslinking (~50kDa and ~12kDa, respectively), and under non-reducing 
conditions (~52kDa and ~15kDa, respectively). Significantly more mature, than promature 
BMP15 was detected (Figure 3.7 A1, B1 and C1). For reference, the results of Figure 3.6 
(described in Section 3.5) indicated that in the 2 µL loaded in the positive control lane of 
each blot there was approximately 1.16 ng of mature BMP15 present. Following 
crosslinking of the recombinant pig BMP15, there was evidence of a possible non-covalent 
mature BMP15 homodimer (~28-30 kDa; Figure 3.7 C1). The positive control also contained 
an unknown band at ~74 kDa which was present in the crosslinked and non-crosslinked 
recombinant pig BMP15 under reducing conditions (Figure 3.7 B1 and C1). However a 
similar sized band was also observed in the negative control (recombinant HEK-293-
produced pig GDF9 conditioned media) under reducing conditions, which indicates that this 
band may be a non-specific target which is expressed by HEK-293 cells during recombinant 
protein production. The recombinant pig BMP15 positive control also had two additional 
unknown bands at ~150-250 kDa that were only present only when crosslinked (Figure 3.7 
C1).  These bands do not correspond with the molecular weight of any known dimer forms 
of BMP15, but may represent multimers of BMP15 with other proteins. Under non-
reducing conditions, the positive control showed two very faint unknown bands at ~90-120 
kDa which could possibly represent a homodimer of promature BMP15 (Figure 3.7 A1). 
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However, the absence of this band in the crosslinked blot (Figure 3.7 C1) makes this 
unlikely. Furthermore, all evidence in the literature to date indicates that the dimer formed 
between two promature monomers of BMP15 is non-covalent, which means any homo or 
heterodimers should dissociate when exposed to SDS in the non-reducing loading buffer. 
There were no bands visible in the negative control lane aside from the one faint band at 
~74 kDa under reducing conditions which was mentioned earlier.  
 
The preabsorption of the Mab61A antibody with E.coli-produced ovine BMP15 resulted in 
no visible bands under any conditions (Figures 3.7). This adds weight to the assumption 
that the bands observed were due to specific binding of the primary antibody to BMP15.  
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Figure 3.7: The molecular forms of BMP15 present in, and secreted from, rat oocytes. (A1), (B1) and 
(C1) represent Western blots performed under non-reducing conditions, reducing conditions and 
reducing conditions where the proteins were crosslinked, respectively. In each blot, Lane 1 contains 2μL 
of recombinant HEK-293-produced pig BMP15 conditioned media (positive control), Lane 2 contains the 
lysate from 200 rat oocytes, Lane 3 contains the conditioned media (CM) from 250 rat oocytes, Lane 4 
contains 2μL of recombinant HEK-293-produced pig GDF9 conditioned media (negative control). Lane 5, 
separated by a black border, represents the results from Lane 3 which have been exposed for 4x the 
original exposure time, and have had black levels increased in an attempt to increase the sensitivity of 
band detection in the oocyte conditioned media samples. (A2), (B2) and (C2) represent the blots of (A1), 
(B1), and (C1), respectively after they have been stripped and re-probed with Mab61A that had been 
preabsorbed with 3x w/w E.coli-produced ovine BMP15. The blots shown are representative of three 
independent replicates, each of which produced similar results. 
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3.7 The molecular forms of BMP15 in, and secreted from, 
oocytes of sheep (litter size 1-3) 
 
A series of Western blots were performed using the sheep oocyte lysate and sheep oocyte 
conditioned media samples. Representative Western blots are shown in Figure 3.8. A total 
of 100 lysed sheep oocytes or conditioned media from culturing 125 sheep oocytes were 
used per lane. 
 
Bands representing promature and mature BMP15 were observed in the oocyte lysates 
under all conditions (non-reducing, reducing and crosslinked; Figures 3.8 A1, B1 and C1, 
respectively). The promature bands were considerably denser than the mature BMP15 
bands in each case. Promature BMP15 appeared as two high density bands in the oocyte 
lysate samples under reducing (with or without crosslinking) (~44-48 kDa; Figures 3.8 B1 
and C1), and non-reducing (~47-51 kDa; Figure 3.8 A1) conditions. The same band shift 
observed between reducing and non-reducing conditions was also observed in rats (Figure 
3.7), pigs (Figure 3.9) and deer (Figure 3.10), and is described in more detail in Section 3.6. 
Mature BMP15 was observed in oocyte lysates as a single band of moderate density under 
reducing (with or without crosslinking) (~13 kDa; Figures 3.8 B1 and C1) and non-reducing 
conditions (~16-17 kDa; Figure 3.8 A1). The single ~16kDa band directly above the mature 
band in the oocyte lysate sample on the reducing blot was not observed in the other two 
replicates (Figure 3.8 B1). 
 
In the oocyte conditioned media, faint single/double bands representing promature 
BMP15 were observed under reducing and non-reducing conditions (~44-51 kDa; Figures 
3.8 A1 and B1), however a promature band was not visible once the samples were 
crosslinked (Figure 3.8 C1). It is possible that the promature protein band in the crosslinked 
(reducing) sample was below detection limits due to the low levels of protein in the oocyte 
conditioned media samples. Mature BMP15 appeared as faint bands with similar molecular 
weights to the mature bands observed in the oocyte lysate samples. The forms of protein 
observed in the positive control were identical under each condition to those described in 
Section 3.6. 
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The oocyte lysate samples had a laddering of unknown bands observed around the 
promature band which was particularly prominent under reducing conditions (Figure 3.8 
B1). The absence of these bands following crosslinking (Figure 3.8 C1) suggests that it was 
unlikely to be due to complex formation involving BMP15 with either itself or other 
proteins. A smear of unknown bands also appeared between ~60-150 kDa under each 
condition. The position of bands in this region varied between replicates, and so they were 
not interpreted further. The lack of a consistent band at ~100kDa following crosslinking 
(Figure 3.8 C1) means there was no evidence for the presence of promature BMP15 
homodimers or heterodimers in either the oocyte lysate or oocyte conditioned media. In 
either the oocyte conditioned media or the oocyte lysates, there were no bands visible in 
the ~25-30 kDa region following crosslinking providing no evidence to support the presence 
of mature BMP15 homodimers or heterodimers (Figure 3.8 C1). There was a band in this 
region in the oocyte lysate samples under reducing conditions (Figure 3.8 B1), however this 
band is unlikely to represent a dimer as the non-covalent dimers should have dissociated 
under the reducing conditions, and is not present following cross-linking (Figure 3.8 C1).  
 
In the oocyte lysate samples there were bands between 150-250 kDa which consistently 
appeared in the non-reducing  and cross-linked (reducing) oocyte lysate samples (Figures 
3.8 A1 and C1, respectively), but were less obvious under reducing conditions (Figure 3.1 
B1). Similar sized bands were also present in the oocyte conditioned media samples under 
non reducing conditions. These bands may indicate the presence of large covalently and 
non-covalently bound protein complexes that includes multimers of the different forms of 
BMP15 together with other proteins. 
 
The preabsorption of the Mab61A antibody with E.coli-produced ovine BMP15 resulted in 
an absence of bands (Figure 3.8 A2, B2 and C2) which supports the assumption that bands 
observed in the Mab61A labelled blots were due to specific binding of the primary 
antibody. 
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Figure 3.8: The molecular forms of BMP15 present in, and secreted from sheep oocytes. (A1), (B1) and 
(C1) represent Western blots performed under non-reducing conditions, reducing conditions, and 
reducing conditions where the proteins were crosslinked, respectively. In each blot, Lane 1 contains 2μL 
of recombinant HEK-293 produced pig BMP15 conditioned media (positive control), Lane 2 contains the 
lysate from 100 sheep oocytes, Lane 3 contains the conditioned media from 125 sheep oocytes, Lane 4 
contains 2μL of recombinant HEK-293 produced pig GDF9 conditioned media (negative control). Lane 5, 
separated by a black border, represents the results from Lane 3 that have been exposed for 4x the 
original exposure time, and have had black levels increased in an attempt to increase the sensitivity of 
band detection in the oocyte conditioned media samples. (A2), (B2) and (C2) represent the blots of (A1), 
(B1), and (C1) respectively, after they have been stripped and re-probed with Mab61A which had been 
preabsorbed with 3x w/w E.coli-produced ovine BMP15. The blots shown are representative of three 
independent replicates, each of which produced similar results. 
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3.8 The molecular forms of BMP15 in, and secreted from, 
oocytes of pigs (litter size 14-22) 
 
 
The same series of Western blots performed in Figures 3.7 and 3.8 were also performed 
using the oocytes of pigs (Figure 3.9). A total of 80 and 100 pig oocytes were used per lane 
for oocyte lysate and oocyte conditioned media samples, respectively. 
 
Promature and mature BMP15 were observed in the oocyte lysate samples under all 
conditions (Figures 3.9 A1, B1 and C1, respectively). Promature BMP15 appeared as one or 
two high density ~49-52 kDa bands in the oocyte lysate samples under all three conditions. 
Interestingly, although the apparent molecular weight of the promature protein did appear 
slightly larger under non-reducing conditions compared to reducing conditions, the shift 
was not as pronounced as what was observed in the other three species. Mature BMP15 
appeared as a single band of moderate density under reducing conditions, with or without 
crosslinking (~11-12 kDa; Figures 3.9 B1 and C1), and under non-reducing conditions (~15-
16 kDa; Figure 3.9 A1).  
 
In the oocyte conditioned media samples under all three conditions there were faint single 
bands representing promature and mature BMP15, each of which had the same molecular 
weights as the equivalent bands in the oocyte lysate samples (Figure 3.9 A1, B1 and C1). 
The forms of protein observed in the recombinant HEK-293 produced pig BMP15 
conditioned media (positive control) were identical under each condition to those 
described in Section 3.6.  
 
There was a faint laddering of unknown bands around the promature band in the oocyte 
lysate samples under reducing conditions (Figure 3.9 B1), but absent under the other two 
conditions (Figure 3.9 A1 and C1). A similar laddering effect was observed in the oocyte 
lysates of sheep and deer (Figures 3.8 and 3.10); however, in their case the bands were 
much more prominent. The absence of these bands following crosslinking (Figure 3.9 C1) 
suggests they are unlikely to be due to any BMP15 complex involving either another BMP15 
molecule or other proteins.  
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A smear of unknown bands appeared between ~60-150 kDa in the oocyte lysate samples 
under each condition, similar to what was observed in the oocyte lysates of sheep and deer 
(Figures 3.8 and 3.10). As was the case with the sheep and deer samples, the position of 
bands in this region varied between replicates of the pig oocyte blots, and so they were not 
interpreted further. There was no consistent band at ~100kDa, or at ~25-30kDa following 
sample crosslinking (Figure 3.9 C1) thus there is no supporting evidence for the presence 
of either promature or mature BMP15 homodimers or heterodimers either within or 
secreted from the oocyte. There were bands between ~150-250 kDa in the oocyte lysate 
and oocyte conditioned media samples under non-reducing conditions and following 
crosslinking (Figure 3.9 A1 and C1) that were absent in non-crosslinked samples under 
reducing conditions (Figure 3.9 B1). These bands were similar to those observed in sheep 
and deer (Figure 3.8 and 3.10, respectively). As with the other species, these may indicate 
the presence of large covalently and non-covalently bound multimer complexes.  
 
As observed previously, the preabsorption of the Mab61A antibody with E.coli-produced 
ovine BMP15 resulted in an absence of the bands detected (Figure 3.9 A2, B2 and C2). This 
supports the assumption that the bands observed were likely due to specific binding of the 
antibody. 
 
 
 
59 
 
 
Figure 3.9 The molecular forms of BMP15 present in, and secreted from pig oocytes. (A1), (B1) and 
(C1) represent Western blots performed under non-reducing conditions, reducing conditions, and 
reducing conditions where the proteins were crosslinked, respectively. In each blot, Lane 1 contains 2μL 
of recombinant HEK-293 produced pig BMP15 conditioned media (positive control), Lane 2 contains the 
lysate from 80 pig oocytes, Lane 3 contains the conditioned media from 100 pig oocytes, Lane 4 contains 
2μL of recombinant HEK-293 produced pig GDF9 conditioned media (negative control). Lane 5, 
separated by a black border represents the results from Lane 3 which have been exposed for 4x the 
original exposure time, and have had black levels increased in an attempt to increase the sensitivity of 
band detection in the oocyte conditioned media samples. (A2), (B2) and (C2) represent the blots of (A1), 
(B1), and (C1), respectively (without the overexposed conditioned media lane) after they have been 
stripped and re-probed with Mab61A which had been preabsorbed with 3x w/w E.coli-produced ovine 
BMP15. The blots shown are representative of three independent replicates, each of which produced 
similar results. 
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3.9 The molecular forms of BMP15 in, and secreted from, 
oocytes of red deer (litter size=1) 
 
The same series of Western blots performed in Figures 3.7, 3.8 and 3.9 were performed 
using deer oocytes (Figure 3.10). A total of 100 and 125 deer oocytes were used for oocyte 
lysate and oocyte conditioned media samples per lane respectively. 
 
Both promature and mature BMP15 was present in the oocyte lysate and oocyte 
conditioned media samples under all three conditions tested (Figures 3.10 A1, B1 and C1). 
There appeared to be more promature BMP15 present than mature BMP15 in the deer 
oocyte lysate samples (Figure 3.10), which was similar to what was observed in rat, sheep 
and pig oocytes (c.f. Figures 3.7, 3.8 and 3.9). The oocyte conditioned media samples, had 
significantly less BMP15 present than the oocyte lysate samples, but both molecular forms 
could be detected under all three conditions (Figure 3.10 A1, B1 and C1). In the oocyte 
lysate samples, promature BMP15 appeared as two high density bands under reducing 
conditions, with or without crosslinking (Figure 3.10 B1 and C1; ~43-49 kDa), and under 
non-reducing conditions (Figure 3.10 A1; ~45-51 kDa). Mature BMP15 appeared as a single 
medium density band at ~13-14kDa under reducing conditions (with or without 
crosslinking), and ~16kDa under non-reducing conditions. In the oocyte conditioned media 
samples, the promature and mature bands were much fainter, and appeared as single or 
double bands with similar molecular weights to the equivalent bands in the oocyte lysate 
samples. The apparent molecular weight  shift of the promature and mature bands under 
non-reducing conditions compared to reducing conditions was similar to what was 
observed in sheep and rats (Figures 3.7 and 3.8, described in Section 3.6). The forms of 
protein observed in the recombinant HEK-293 produced pig BMP15 conditioned media 
positive control were identical under each condition to those described in Section 3.6.  
  
There was a laddering of high density unknown bands around the promature band in the 
oocyte lysate samples under reducing conditions, and to a lesser extent under non-
reducing conditions (Figure 3.10 B1 and A1, respectively) which was similar to what was 
observed in the oocyte lysates of sheep (Figure 3.8). The high density and close proximity 
of these unknown bands under reducing conditions resulted in the coagulation of signal 
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shown in Figure 3.10. However, when densitometric analysis was performed for later 
figures (Figures 3.13-3.15), a lower exposure of the blots were used for band separation. 
The laddering effect is lessened after sample crosslinking (Figure 3.10 C1). This makes it 
unlikely that these bands are due to any sort of BMP15 complex. The distinct band at 
~30kDa in the oocyte lysate under non-reducing conditions (Figure 3.10 A1) was not 
present in either of the other two replicates so was not interpreted any further. There was 
a smear of unknown bands between ~60-150 kDa in the oocyte lysate samples under each 
condition (Figure 3.10), similar to what was observed in the oocyte lysates of sheep and 
pigs (Figures 3.8 and 3.9). Once again, there were no distinct bands observed consistently 
across replicates in this region so no firm conclusions could be drawn about the proteins 
present. The absence of a consistent band at ~100kDa, or at ~25-30kDa following sample 
crosslinking (Figure 3.10 C1) means there is no supporting evidence for the presence of 
either promature or mature BMP15 homodimers or heterodimers either within or secreted 
from the oocyte. There were bands between ~150-250 kDa in the oocyte lysate samples 
under non-reducing conditions and reducing conditions with crosslinking (Figure 3.10 A1 
and C1). These bands were less marked under reducing conditions without crosslinking 
(Figure 3.10 B1). This observation was consistent amongst replicate blots, and was similar 
to what was observed in the oocyte lysates of the sheep and pig (Figures 3.8 and 3.9, 
respectively). Similar bands were observed in the oocyte conditioned media samples 
(Figure 3.10). As with the other species, these bands may indicate the possible presence of 
large covalently and non-covalently bound BMP15 complexes.  
 
Probing blots with Mab61A that had been preabsorbed with E.coli-produced ovine BMP15 
resulted in no detectable bands (Figure 3.10 A2, B2, C2), which was similar to what was 
observed in rat, sheep and pig oocytes (Figures 3.7, 3.8, and 3.9, respectively). A faint band 
at ~45kDa was most likely due to the incomplete stripping of the dense promature BMP15 
band. The fact that the bands all disappeared (or faded dramatically) following 
preabsorption of the primary antibody suggests that the bands observed in Figures 3.10 
A1, B1 and C1 were most likely due to specific binding of the primary antibody to deer 
BMP15.  
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Figure 3.10: The molecular forms of BMP15 present in, and secreted from deer oocytes. (A1), (B1) and 
(C1) represent Western blots performed under non-reducing conditions, reducing conditions, and 
reducing conditions where the proteins were crosslinked, respectively. In each blot, Lane 1 contains 2μL 
of recombinant HEK-293 produced pig BMP15 conditioned media (positive control), Lane 2 contains the 
lysate from 100 deer oocytes, Lane 3 contains the conditioned media from 125 deer oocytes, Lane 4 
contains 2μL of recombinant HEK-293 produced pig GDF9 conditioned media (negative control). Lane 5, 
separated by a black border, represents the results from lane 3 which have been exposed for 4x the 
original exposure time, and have had black levels increased in an attempt to increase the sensitivity of 
band detection in the oocyte conditioned media samples. (A2), (B2) and (C2) represent the blots of (A1), 
(B1), and (C1), respectively (without the overexposed conditioned media lane) after they have been 
stripped and re-probed with Mab61A which had been preabsorbed with 3x w/w E.coli-produced ovine 
BMP15. The blots shown are representative of three independent replicates, each of which produced 
similar results. 
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3.10 The alignment of intra-oocyte and oocyte-secreted 
molecular forms of BMP15 with those of GDF9 in rats, sheep, 
pigs and deer 
 
 
In order to determine whether any of the bands detected in the oocyte lysate or oocyte 
conditioned media samples were due to interactions of BMP15 with GDF9 at a molecular 
level, one of the replicate blots demonstrated in Figures 3.7-3.10 was stripped and re-
labelled with Mab37A (Figure 3.11). Mab37A is a monoclonal antibody targeting the 
mature GDF9 peptide. The blots that were stripped and labelled with Mab37A had already 
previously been stripped and re-labelled the anti-β-actin antibody. The band observed at 
~42-46 kDa in all the GDF9 oocyte lysate blots, which was particularly prominent in the deer 
oocyte lysate blots, was likely due to incomplete stripping of the dense β-actin band. 
Evidence for this was provided by overlaying the β-actin labelled blots with the GDF9 
labelled blots whereby the bands aligned perfectly (data not shown). The reader should not 
be misled into comparing the relative apparent densities of the BMP15 bands with the 
GDF9 bands. The blots that were immunoprobed for GDF9 underwent a longer exposure 
time during imaging than the BMP15 blots to compensate for the loss of protein during 
stripping. Due to this manipulation, the blots may only be used to compare the relative 
molecular weights of the bands rather than the band intensities. The purpose of these blots 
was to elucidate whether BMP15:GDF9 interactions exist.  
 
In each blot, promature GDF9 was slightly larger (~55-60kDa) than that observed for 
promature BMP15. Mature GDF9 also appeared slightly larger than its BMP15 counterpart, 
under both reducing (~17-20 kDa) and non-reducing (~20-25 kDa) conditions. Many of the 
anti-GDF9 blots of the sheep, pig and deer oocyte lysates had an additional unknown band 
with the same molecular weight as the mature BMP15 band which may represent slight 
cross reactivity of Mab37A towards the mature BMP15 protein.  The laddering of unknown 
bands between ~30-45 kDa that was observed the deer pig and sheep oocyte lysate 
samples (as described in Sections 3.7, 3.8 and 3.9) did not appear to correlate with any 
similar GDF9 bands. Thus, it is unlikely that these bands were due to the formation of 
complexes between the two proteins. A faint unknown band observed at ~55-60 kDa in the 
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oocyte lysates of many of the BMP15 labelled blots appeared to correlate with the dense 
promature GDF9 band observed in blots labelled for GDF9. This suggests that the band may 
be due to potential cross reactivity of Mab61A towards the GDF9 promature protein. 
However, preabsorption experiments indicated only extremely low cross reactivity towards 
GDF9 (Figure 3.3), and there was no cross-reactivity observed in the recombinant HEK-293 
produced pig GDF9 control in each blot (see appendix IV for representative full blot with 
control lanes). Furthermore, the ~55-60 kDa band in the BMP15 labelled blot was not 
consistent across all of the replicates, and therefore it is unlikely that cross-reactivity was 
the cause of the band. It may simply be a coincidence that the bands share similar 
molecular weights. 
 
There were no bands observed consistently between the three repeats in the ~60-140 kDa 
region of the BMP15 or GDF9 labelled blots, and so no comparisons could be made 
between the BMP15 and GDF9 labelled blots in this region. The lack of consistent bands in 
this region does not completely rule out the possibility of homodimeric or heterodimeric 
forms of BMP15 and GDF9 in the oocyte lysate samples as there was a smearing of bands 
in this region for both proteins in the sheep, deer and pig samples. However under the 
conditions used, there was no evidence to support the existence of these forms both within 
and secreted by the oocyte. There were, however, consistent anti-BMP15 labelled bands 
observed in the ~140-212 kDa region in sheep, pig and deer samples under  non-reducing 
conditions and in cross-linked samples under reducing conditions (described in Section 3.7, 
3.8 and 3.9). These bands aligned well with similar sized bands in the anti-GDF9 labelled 
samples, which showed a similar pattern across the three conditions used. This allows for 
the possibility that the bands represent high molecular weight non-covalently and 
covalently bound multimeric complexes which include different forms of both BMP15 and 
GDF9.  
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Figure 3.11: Comparisons between the intra-oocyte and oocyte secreted molecular forms of BMP15 
and GDF9 detected using Mab61A and Mab37A, respectively. The letters for each blot represent the 
species used for each blot (A=sheep, B=pig, C=Deer and D=Rat). The blots were performed under non-
reducing conditions, reducing conditions or reducing conditions where the proteins were crosslinked, 
respectively (indicated by the column header). In each blot, Lanes 1 and 2 have been labelled with the 
anti-BMP15 antibody Mab61A. Lane 1 represents the oocyte lysate samples for each species. 100 sheep 
oocytes, 80 pig oocytes, 100 deer oocytes and 200 rat oocytes were used for the oocyte lysate samples. 
Lane 2 represents the oocyte conditioned media samples for each species and has been overexposed 
for band detection purposes. 125 sheep oocytes, 100 pig oocytes, 125 deer oocytes and 250 rat oocytes 
were used for the oocyte conditioned media samples. Lanes 3 and 4 represent Lanes 1 and 2 after having 
been stripped and re-probed with the anti-GDF-9 antibody Mab37A. A full blot example with all control 
lanes is provided in Appendix IV. 
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3.11 Models for the quantification and normalisation of the 
BMP15 band densities across blots 
 
A series of experiments were performed to determine whether quantification and 
comparison of both promature and mature BMP15 across blots was possible. The 
antibodies were used at saturation levels (based on antibody titrations, data not shown). A 
Western blot containing titrations of pig oocyte lysate was labelled with Mab61A, then 
stripped and labelled with β-actin (figure 3.12 A and B). While promature BMP15 bands 
were detectable in as few as 9 oocyte lysates, mature BMP15 and β-actin were not detected 
when fewer than 38 and 19 oocyte lysates were used respectively. The densities of these 
bands were measured, and plotted to determine the linear dynamic range (Figure 3.12 C). 
All of the detectable mature and β-actin bands showed a strong linear relationship with 
increasing oocyte number, and the promature BMP15 bands also showed a strong linear 
relationship between 9 and 150 oocyte lysates (R2 > 0.99 ) (Figure 3.12 C). However, when 
300 oocyte lysates were used, the band density was lower than expected and did not 
conform to the linear trend (data point not plotted). This may indicate that the saturation 
point for the dense promature BMP15 bands lies between 150 and 300 oocyte lysates in 
pigs.  
The data points in the linear dynamic range from Figure 3.12 C were converted into 
proportions of the maximum band density and sample amount values and then plotted 
(figure 3.12 D). There were no significant differences between the linear regressions of 
each protein and all three proteins aligned well with the predicted quantitative response 
for a protein below saturation levels. This indicates that the band densities of each protein 
provide an accurate representation of the relative amounts of protein present, provided 
the bands fall within the linear dynamic range. For example, if a given sample contains half 
as much mature BMP15 as another sample, it can be expected to have half the band 
density. It was not a viable use of time and resources to collect all the oocytes required to 
perform Figures 3.12 A-D with the oocyte lysates of rats, sheep and deer, or the oocyte 
conditioned media of each species. Instead it was simply assumed that the values of all 
bands detected fell within the linear dynamic range provided they were less dense than the 
promature band found using 300 pig oocyte lysates. 
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The results illustrated in Figure 3.12 B-D suggested that β-actin was a viable option for 
normalisation of protein levels across blots as it appeared to handle large sample sizes 
without reaching saturation. When an anti-β-actin antibody was used against the blots in 
Figures 3.7- 3.10, β-actin was detected in the oocyte lysate samples in each blot, but was 
predictably absent from all the conditioned media samples (a sample full blot is provided 
in Figure 3.12 F, and the β-actin band from each blot of one of the repeats is shown in 
Figure 3.12 E). The β-actin levels were very low in the pig compared to the other three 
species (Figure 3.12 E), which is likely due to pig oocytes mostly being recovered in a 
denuded state (i.e. absent of cumulus cells), compared to that in the other three species.  
   
3.12 Comparison between the levels of intra-oocyte and 
oocyte secreted promature and mature forms of BMP15 in 
rats, sheep, pigs and deer normalised using β-actin 
 
Densitometric analysis was performed on the three replicates of the reducing blots (B1) 
displayed in Figures 3.7 to 3.10 using Image J software. The densities of the promature and 
mature band found in both the oocyte lysate and oocyte condition media samples were 
calculated for each species. The blots were then stripped and relabelled for the 
constitutively active β-actin protein, which was present in the oocyte lysates of all species 
(see Figure 3.12 and Section 3.11). The BMP15 band densities were then normalised using 
the β-actin band densities according to Section 2.1.6, and the resulting values are 
presented in Figure 3.13. Only the reducing blots were used for densitometric analysis as 
they were deemed to give the fairest representation of the absolute levels of promature 
and mature BMP15 present as they include proteins which may be lost into unknown 
protein complexes under non-reducing or crosslinked conditions. 
 
In the oocyte lysate samples, there was more promature BMP15 than mature BMP15 in all 
four species (P≤ 0.05) (Figure 3.13 A). In the oocyte conditioned media samples the 
difference in levels was much less pronounced. Only the deer exhibited higher levels of  
 
 
 
68 
 
 
 
69 
 
Figure 3.12: Tests performed to investigate reliability of the quantification and normalisation of the 
BMP15 band densities across blots. (A) Detection of BMP15 in a titration of pig oocyte lysates under 
reducing conditions using MAB61A. The number of oocytes is indicated above each lane in Lanes 1-8. 
Lane 9 is a positive control and contains 2 µL of recombinant HEK-293 produced pig BMP15. Lanes 10 
and 11 are negative controls containing 2 μL of untransfected HEK-293 conditioned media and 2μL of 
recombinant HEK-293 produced pig GDF9 conditioned media, respectively. The position of the 
promature and mature BMP15 bands are indicated next to the blots (B) The blot from (A) was stripped 
and reprobed with an anti-β-actin antibody (Product # A5441, Sigma Aldrich). The position of the β-actin 
bands is indicated next to the blot. (C) The band densities from (A) and (B) were plotted against the 
number of pig oocytes in the sample. When bands were absent or when the band density fell outside of 
the linear range the data point was omitted. The data points on the graph were fitted with linear 
regression lines and the equations and R2 values shown are allocated according to the colour and key 
provided in the figure. (D) The band densities from (C) were converted into a proportion of the highest 
band density for each given protein type, and the number of oocytes was converted into a proportion 
of the highest number of oocytes in the linear range for each protein shown in (C). The values were 
plotted and fitted with linear regression lines. The black dotted line represents the predicted 
quantitative response whereby an increase in sample causes a proportional increase in the band density. 
Each linear regression shown had an R2 greater than 0.98. There was no significant difference between 
the linear regressions of each of the proteins and the predicted quantitative response. (E)  The β-actin 
bands detected in the oocyte lysates of each species under non-reducing conditions, reducing 
conditions, and finally conditions where the proteins were crosslinked before being run under reducing 
conditions. The species type and number of oocyte lysates used is indicated above each band. The 
numbers in the grey shaded area underneath each band represent the average density units for the 
band across three replicate experiments. (F) An example of a full blot (sheep oocyte lysate, reducing 
conditions) from (D). Lane 1 contains 2 μL of recombinant HEK-293 produced pig BMP15 conditioned 
media (positive control), Lane 2 contains the lysate from 100 sheep oocytes, Lane 3 contains the 
conditioned media from 125 sheep oocytes, Lane 4 contains 2μL of recombinant HEK-293 produced pig 
GDF9 conditioned media (negative control). 
 
 
promature than mature BMP15 (P<0.05), and no differences were observed in sheep and 
pigs (Figure 3.13 B). There were no bands for either protein observed in the rat oocyte 
conditioned media samples across any of the replicates. 
 
The levels of each molecular form were also compared across the four species. Overall, 
there were species effects on the levels of promature or mature BMP15 in the oocyte 
lysates samples (P ≤ 0.0001), and the oocyte conditioned media samples (P ≤ 0.01) (see 
Figure 3.13 A and B). In the oocyte lysate samples, pigs had significantly more promature 
and mature BMP15 than the other three species (P<0.05) (BMP15:β-actin ratio of 11.8 and 
0.72, respectively), followed by deer (BMP15:β-actin ratios of 6.9 and 0.26, respectively) 
and sheep (BMP15:β-actin ratio of 4.7 and 0.18, respectively) which had similar amounts 
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to one another. Rat oocyte lysates contained significantly less promature and mature 
BMP15 than the other three species (BMP15: β-actin ratio of 0.2 and 0.03, respectively).  
 
In the oocyte conditioned media samples, pig oocytes secreted the most promature BMP15 
(P<0.05) (BMP15:β-actin ratio of 0.23), followed by deer (BMP15:β-actin ratio of 0.06) and 
sheep (BMP15:β-actin ratio of  0.05) which once again had similar amounts to one another. 
In regards to the mature protein, pigs secreted more than deer (P<0.05) (BMP15:β-actin 
ratios of  0.11 and 0.01 respectively), but there was no difference between sheep 
(BMP15:β-actin ratio of 0.03) and deer, or sheep and pigs. The rat conditioned media was 
excluded from comparisons because no BMP15 bands were detected.  
 
 
3.13 Comparisons between the levels of intra-oocyte and 
oocyte-secreted promature and mature forms of BMP15 in 
rats, sheep, pigs and deer with the levels expressed relative 
to the number of oocytes per sample, and normalised using 
the mature BMP15 band in the positive control 
 
There were concerns that standardising the levels of BMP15 across species using β-actin as 
described in the previous section may have some limitations. This is because, despite best 
efforts to denude the oocytes during collection, the oocytes of some species were more 
successfully denuded than others (as outlined in Section 2.1.2). While all pig oocytes 
collected were fully denuded, the oocytes of the other three species were collected as a 
mixture of fully and partially denuded oocytes. The partially denuded oocytes still had a 
small number of cumulus cells attached and attempts were not made remove these due to 
the risk of oocyte rupture. The presence of these cumulus cells would have contributed to 
the β-actin levels detected in the oocyte lysate samples of the rat, sheep and deer, but not 
the pig, which could have potentially skewed the results. Thus, an alternative means of 
comparing the BMP15 levels between species is presented in Figure 3.14 whereby the 
bands were adjusted for the number of oocytes used per sample, and the levels were  
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Figure 3.13: Levels of intra-oocyte and oocyte secreted promature and mature BMP15 detected under 
reducing conditions in each species relative to the β-actin levels detected for each species. The 
experiments in Figures 3.6-3.9 were performed in triplicate and the densities of the bands in the 
reducing blots were measured. The values presented represent the mean target-BMP15 to β-actin band 
density ratio. The vertical error bars represent ±SEM. Statistical analysis was performed according to 
Section 2.1.6. Different letters above the columns for a given protein form indicate a significant 
difference between species (e, f and g are used for the promature protein values and w, x and y are used 
for the mature protein values) (P ≤ 0.05). The same letter above two or more columns indicates no 
significant difference between them. Brackets indicate significant differences between the promature 
and mature protein values within each species (* = P ≤ 0.05, ** = P ≤ 0.01, **** = P ≤ 0.0001, ns= not 
significant). N/A= No BMP15 detected.  (A) The levels of promature and mature BMP15 in the oocyte 
lysate of each species. A broken y-axis is used due to the low levels of mature protein observed relative 
to the promature protein. (B) The levels of promature and mature BMP15 detected in the oocyte 
conditioned media of each species. As there was no β-actin present in the oocyte conditioned media, 
the values presented represent the mean ratio between the BMP15 band density and 1.25x the mean 
β-actin band density found in the corresponding oocyte lysate samples on each blot. A multiple of 1.25 
was used for the β-actin band density to adjust for the extra 25% oocytes used in the conditioned media 
samples compared to the oocyte lysate sample. 
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normalised using the mature BMP15 band in the positive control for each blot (see Section 
2.1.6 for details). Once again, only the promature and mature bands from the three 
replicates of the reducing blots for each species were analysed.  
 
Firstly, the promature and mature BMP15 levels within each species were compared 
(Figure 3.14 A and B). As expected, the same patterns of intra-species promature versus 
mature protein levels were observed as previously described (see Section 3.12). When 
levels were compared between species, there were significant differences in the levels of 
promature BMP15 in the oocyte lysate samples. When the samples were corrected against 
oocyte number and the positive control, deer exhibited the most promature BMP15 
(adjusted BMP15:+ve control ratio of 20.5), while sheep and pigs had similar levels 
(adjusted BMP15:+ve control ratio of 6.2 and 5.1, respectively) (Figure 3.14A). The level of 
promature BMP15 in the rat oocytes was significantly less than that in the other three 
species (adjusted BMP15:+ve control ratio of ~0.1). The promature BMP15 levels in the 
conditioned media samples showed a similar pattern where the deer oocytes contained 
significantly more promature BMP15 than sheep (adjusted BMP15:+ve control ratios of 
0.19 and 0.07, respectively) (P ≤ 0.05) and sheep and pigs had similar levels. However, there 
was no significant difference between deer and pigs (adjusted BMP15:+ve control ratios of 
0.19 and 0.10, respectively) (Figure 3.14 B). There were no bands of promature BMP15 
detected across the three replicates in the rat oocyte conditioned media samples.  
 
There were significant differences in the levels of mature BMP15 in the oocyte lysate 
samples between species (Figure 3.14A). There was more (P<0.05) mature BMP15 in deer 
oocytes (adjusted BMP15:+ve control ratios of 0.78) compared to sheep and pigs (adjusted 
BMP15:+ve control ratios of 0.26 and 0.31, respectively), which were similar. Mature 
BMP15 levels were lowest (P<0.05) in the oocyte lysate of rats (adjusted BMP15:+ve control 
ratios of 0.01). In the conditioned media samples (Figure 3.14 B), mature BMP15 levels 
were similar between deer, sheep and pigs (adjusted BMP15:+ve control ratios of 0.06, 0.05 
and 0.05, respectively). The rat had the least mature BMP15 in the conditioned media as 
there were no bands detected in any of the three replicates. 
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Figure 3.14: Levels of intra-oocyte and oocyte secreted promature and mature BMP15 detected under 
reducing conditions in each species presented relative to the positive control mature BMP15 band, 
and adjusted for the number of oocytes used per sample. The experiments in Figures 3.6-3.9 were 
performed in triplicate and the densities of the bands in the reducing blots were measured. The BMP15 
values presented represent the mean ratio between the target-BMP15 band and the mature BMP15 
band in the positive control for each blot. Values were adjusted for the number of oocytes used for each 
sample. The vertical error bars represent ±SEM. Statistical analysis was performed according to Section 
2.1.6. Different letters above the columns for a given protein form indicate a significant difference 
between species (e, f and g are used for the promature protein values and w, x and y are used for the 
mature protein values) (P ≤ 0.05). The same letter above two or more columns indicates no significant 
difference between them. Brackets indicate significant differences between the promature and mature 
protein values within each species (* = P ≤ 0.05, *** = P ≤ 0.001, *** = P ≤ 0.0001, ns= not significant). 
N/A= No BMP15 detected.  (A) The levels of promature and mature BMP15 in the oocyte lysate of each 
species. A broken y-axis is used due to the low levels of mature protein observed relative to the 
promature protein. (B) The levels of promature and mature BMP15 detected in the oocyte conditioned 
media of each species.  
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3.14 Differences in the ratio of promature:mature BMP15 
both within the oocyte and secreted by the oocyte in rats, 
sheep, pigs and deer 
 
 
The ratios of promature to mature BMP15 in the oocyte lysate and oocyte conditioned 
media samples under reducing conditions were calculated in order to determine if there 
were differences in the four mammalian species tested (Figure 3.15). In all species, the 
promature:mature ratio was higher (P<0.01) in the oocyte lysate samples compared to the 
oocyte conditioned media samples, indicating a marked drop in the levels of promature 
BMP15 relative to mature BMP15 outside of the oocytes. There were no bands of either 
protein form detected in the oocyte conditioned media of rats and these results were not 
included in the analyses. 
The promature:mature ratios in oocyte lysate were highest (P<0.05) in sheep and deer 
(mean promature:mature BMP15 ratios of ~24.5 and 26.4, respectively), which were 
similar, and lower (P<0.05) in rats and pigs (mean promature:mature BMP15 ratios of 7.8 
and 16.5, respectively) which were also similar to one another (Figure 3.15).  
The promature:mature ratios in oocyte conditioned media were similar between sheep, 
deer and pigs (mean promature:mature BMP15 ratios of 2.3, 4.7 and 2.3, respectively) 
whilst levels in rat oocytes were undetectable (Figure 3.15).  
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Figure 3.15: Differences in the promature:mature ratio in lysates and conditioned media from in rat, 
sheep, deer and pig oocytes under reducing conditions. (A) The experiments in Figures 3.6-3.9 were 
performed in triplicate and the densities of the bands in the reducing blots were measured. The values 
presented represent the average promature:mature BMP15 ratio for each species in either the oocyte 
lysate samples or the oocyte conditioned media samples. The vertical error bars represent ±SEM. 
Statistical analysis was performed according to Section 2.1.6. Different letters above the columns for a 
given sample type indicate a significant difference between species (e and f are used for the oocyte 
lysate values and w is used for the oocyte conditioned media values) (P < 0.05). The same letter above 
two or more columns indicates no significant difference between them (P > 0.05). Brackets indicate 
significant differences between the oocyte lysate and oocyte conditioned media values within each 
species except rat where there was no BMP15 detected in the oocyte conditioned media samples. (**  
P < 0.01, ***  P < 0.001). N/A= No BMP15 detected. 
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Chapter 4 Discussion 
4.1 Comparisons between two different monoclonal 
antibodies which were generated to target different areas 
within the mature BMP15 protein 
 
Previous studies in our laboratory revealed that the monoclonal Mab61A antibody was able 
to detect both the promature, and the mature forms of BMP15 on Western blots (see 
Appendix II; Lin et al., 2012). Due to the finite supply of Mab61A, a new and uncharacterised 
antibody which was generated to target a similar region of BMP15 mature peptide 
(Mab61B) and its efficacy was compared with Mab61A. This study provides valuable insight 
into the variability of detection systems when utilising different monoclonal antibodies to 
the same target protein. This study undertook a series of experiments comparing the two 
antibodies under optimised conditions and revealed that the Mab61B antibody had a lower 
specificity and affinity towards all molecular forms of BMP15, than Mab61A. Moreover, 
Mab61B was unable to detect promature BMP15 in any of the species tested.    
Mab61B required different Western blotting conditions to Mab61A in order to achieve 
optimum labelling of the mature BMP15 bands, and even under optimised conditions, it 
showed lower sensitivity than Mab61A in all species except rat (Figures 3.1 and 3.2). These 
results were surprising because both antibodies target juxtaposed regions of the mature 
peptide with some overlapping sequences. These regions are located towards the N-
terminus of the ovine mature peptide which is believed to be flexible and exposed based 
on 3D model predictions (Juengel & McNatty, 2005; McNatty et al., 2007). Furthermore, in-
vivo immunization of sheep using either of the target sequences chemically conjugated to 
keyhole limpet hemocyan (KLH) elicited a strong immune response and inhibited ovarian 
function, with the Mab61B target sequence shown to be slightly more effective than the 
Mab61A target sequence (McNatty et al., 2007). The reason for the differences in affinities 
between the two antibodies may lie in the fact that both antibodies are monoclonal, and/or 
that they were each generated in a slightly different manner. Monoclonal antibodies target 
a specific epitope, and are sensitive to small changes in the structure of the epitope, and 
factors such as glycosylation may affect their affinity (Lipman et al., 2005). The fact that 
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Mab61B was generated against a short synthetic sequence while Mab61A was generated 
against the entire E.coli-produced mature BMP15 protein may have meant that this 
generation method provided a better model of the native sequence. It is not uncommon 
for an antibody generated against a synthetic peptide to have little or no reactivity towards 
its target protein (Hancock and OReilly, 2005).  The fact that the two antibodies have such 
different binding patterns despite having an 8 amino-acid overlap in their target sites may 
also be explained by the fact that within a given 15 amino-acid epitope, only ~5 amino acids 
contribute the majority of the binding energy (Frank, 2002). Therefore, the remaining 7 
amino acids which are unique to the Mab61A target site may play an important role in 
giving Mab61A a stronger affinity for the protein. The fact that Mab61A could not be fully 
preadsorbed by the Mab61B target sequence (Peptide B in Figure 3.3) supports this.  
Whilst Mab61B was unable to detect promature BMP15 in any of the four species when 
using a 13.5% acrylamide gel (Figures 3.1-3.4); the antibody was capable of detecting 
promature BMP15, albeit with low affinity, in a 7.5% acrylamide gel. This lower 
concentration gel allowed for greater separation between the promature protein and 
similar-sized non-specific target proteins (Figure 3.4). Future experiments required the use 
of 13.5% acrylamide gels in order to make comparisons between the mature and 
promature bands on the same blots. In contrast to Mab61B, Mab61A was able to detect 
both promature and mature BMP15 in all four species on both 13.5% and 7.5% acrylamide 
gels, and had high affinity for the target proteins and low affinities for non-target proteins. 
The high cross-affinities of Mab61B to non-target proteins is uncharacteristic of 
monoclonal antibodies which tend to have high specificity towards their epitope (Lipman 
et al., 2005). The inability of Mab61B to bind the promature protein on 13.5% acrylamide 
gels may be due to non-specific bands of similar molecular weights to the promature band 
blocking the site on the promature protein where the antibody would bind. Another 
possible explanation lies in the target sequences for each antibody. The Mab61B target lies 
directly on the N-terminus of the mature peptide.  N-terminal glutamine residues may 
spontaneously form pyroglutamate under aqueous conditions (Liu et al., 2011). It is 
possible that the exposed glutamine residue at the N-terminal end of the synthetic peptide 
sequence used to generate Mab61B may have become a pyroglutamate residue, as has 
previously been reported in recombinant human BMP15 (Saito et al., 2008). The possible 
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use of this pyroglutamate residue to specifically target mature BMP15 and avoid promature 
BMP15 has been alluded to in previous studies (McMahon, 2007). While further 
experiments are required to determine if the Mab61B target sequence contains the 
pyroglutamate residue, it would certainly explain many of the results observed in this 
study. Explanations aside, it was clear from the comparisons drawn between Mab61A and 
Mab61B that Mab61A was a superior antibody for the purposes of this study and was the 
more suitable of the two antibodies for all subsequent experiments. 
 
4.2 The intra-oocyte and oocyte-secreted molecular forms of 
BMP15 across a range of mammalian species with different 
litter sizes (rats, sheep, deer and pigs) 
 
The Western blots performed using the oocyte lysates of rats, sheep, pigs and deer 
established that both promature and mature BMP15 was present within oocytes of each 
species, and are secreted from the oocytes of sheep, deer and pigs (Figures 3.7-3.10). No 
BMP15 was detected to be secreted from oocytes of rat, possibly due to levels being below 
the detection limits of the methodology used. While the intra-oocyte and oocyte-secreted 
forms of BMP15 has been studied previously in rats and sheep using Mab61A under 
reducing conditions (Lin et al., 2012), the present study provided novel data on two new 
species that have divergent litter sizes (i.e. pigs and deer). The previous study successfully 
detected promature and mature BMP15 in sheep oocyte lysates but only mature BMP15 in 
sheep oocyte conditioned media, and promature BMP15 in rat oocyte lysates (Lin et al., 
2012). In the present study following methodology optimisations that allowed for greater 
detection, a promature BMP15 band was detected in sheep oocyte conditioned media, and 
a faint mature BMP15 band was detected in oocyte lysates of the rat. This latter 
observation had previously been reported in another study using an alternative antibody 
to Mab61A. (Lin et al., 2012). In the present study, the promature and mature bands of the 
rat and sheep had slightly lower molecular weights than what was reported previously by 
Lin et al., 2012. This may be due to variations in the loading buffer that was used to 
dissociate intramolecular disulphide bonds, or differences in the ladder used as the ladder 
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used in the current study had more bands in the 10-25 kDa molecular weight range which 
allowed for a more accurate estimation of the mature band size.  
The observations that promature and mature BMP15 are present within the rat oocyte 
reported in this study and in Lin et al. (2012), and that BMP15 has been shown to stimulate 
rat granulosa cell proliferation in vitro (Moore et al., 2003; Otsuka et al., 2000) might 
suggest that BMP15 plays a role in follicular growth and maturation in this species. 
However, other studies report that only GDF9 is required to enhance granulosa cell 
proliferation in rats (Lin et al., 2012), and BMP15 knockout studies in mice reveal only a 
minor loss in fertility (Lin et al., 2012; Yan et al., 2001). Despite BMP15 being present inside 
the oocytes of rats in the current study, absence of any BMP15 detected outside of the 
oocyte supports the idea that BMP15 is of little importance in rats. It remains possible that 
BMP15 was secreted from the oocytes of rats at levels below detection limits, and the low 
homology between the target sequences of rat and ovine BMP15 for the Mab61A antibody 
may have contributed to the lack of BMP15 detection in the oocyte conditioned media. 
However, the study of Lin et al. (2012) used an alternate antibody with a higher homology 
for rat BMP15 and did not detect BMP15 when using 400 rat oocytes. 
As mentioned previously, BMP15 has been viewed as having a lesser importance in 
mammalian species with high litter sizes, whereby it is thought to have a secondary role to 
GDF9 (Crawford and McNatty, 2012; Yan et al., 2001). However this study provides novel 
data on the presence of promature and mature BMP15 protein both within and secreted 
from the oocytes of pigs, which have a high litter size (14-22 offspring/litter). Moreover, 
the levels of BMP15 proteins within pig oocytes are similar to that in sheep and deer, which 
have low litter sizes (1-3 and 1 offspring/litter, respectively) (Figures 3.8-3.10, 3.14). These 
results are substantiated by reports that BMP15 is actively transcribed during oocyte 
development in the pig, and that BMP15 may improve oocyte maturation in-vitro, with 
roles including the prevention of cumulus cell apoptosis (Crawford & McNatty, 2012; Lin et 
al., 2014; Paradis et al., 2009; Zhai et al., 2013). 
The promature form of BMP15 that is present in the oocyte lysates of all four species, and 
in the oocyte conditioned media of sheep, deer and pigs appeared to be in an uncleaved 
form as evidenced by a promature band under reducing conditions. Unprocessed 
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promature BMP15 was to be expected within the oocyte as current evidence suggests 
BMP15 is produced in the same manner as all TGF-β proteins, whereby it is produced as 
preproproteins, with the pre-region removed during translocation into the rough 
endoplasmic reticulum (RER) (Chang et al., 2002; Dube et al., 1998). Furthermore, high 
levels of intra-oocyte promature BMP15 has been observed in a number of studies 
(Guéripel et al., 2006; Lin et al., 2012). More noteworthy was the observation of 
unprocessed promature BMP15 forms secreted by the oocytes of sheep, deer and pigs. This 
is because typically only the mature region of the TGFβ superfamily members is biologically 
active, and removal of the proregion from the mature peptide usually occurs intracellularly 
before secretion from the oocyte (Shi et al., 2011; Shimasaki et al., 2004). However, it is 
not uncommon for a cleaved proregion of TGFβ superfamily proteins to remain non-
covalently associated with their corresponding mature peptides in a latent complex (Shi et 
al., 2011). This study provides evidence that not all promature BMP15 is cleaved upon 
secretion from the oocyte in sheep, deer and pigs. While secreted uncleaved promature 
forms are not common amongst the other TGFβ superfamily members, a number of studies 
using recombinant cell lines producing human, sheep or mouse BMP15 have observed 
uncleaved promature forms in the conditioned media, and one study reported its presence 
in oocyte secreted media (Hashimoto et al., 2005; McIntosh et al., 2008; McMahon et al., 
2008; McNatty et al., 2006; Mester, 2013; Reader et al., 2011).  
The presence of unprocessed promature BMP15 in the oocyte secreted media of sheep, 
deer and pigs suggests that it may have a biological function. Extracellularly, the proregions 
of TGF-β superfamily proteins are reported to act as chaperones for delivering the mature 
ligand to their target cells. The hypothesised mechanism of action is that the proregion 
interacts with the extracellular matrix and also with potential proregion targets such as 
heparin which are expressed differentiationally on the extracellular domain of granulosa 
cells and cumulus cells, and mediate the presentation of the mature peptide to the surface 
receptors (Harrison et al., 2011; Mottershead et al., 2015; Sengle et al., 2008). Therefore, 
the promature BMP15 secreted from the oocytes of sheep, pigs and deer may allow each 
species to have additional extracellular mechanisms for species-specific regulation of 
BMP15 signalling. Few studies have investigated the biological activity of uncleaved 
promature BMP15, however one such study demonstrated that it is biologically active 
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(Mester, 2013), and it may be more effective at increasing bovine embryo development 
than mature BMP15, mature GDF9, or promature GDF9 (Sudiman et al., 2014). 
Furthermore, a heterodimeric complex between promature BMP15 and promature GDF9 
(named pro-cumulin) has been demonstrated to elicit potent bioactivity on ovine granulosa 
cells and oocytes, as well as improve oocyte quality and embryo development 
(Mottershead et al., 2015). It should be noted that the model presented in the study by 
Mottershead et al., 2015 believed the promature proteins in the pro-cumulin complex 
existed in a semi-processed state, where the proregions were non-covalently associated 
with the mature regions. However, this model was based on the assumption that BMP15 is 
processed in the same manner as other TGF-β proteins, and therefore all the secreted 
promature BMP15 is in a semi-processed state. While the results from this current study 
do not rule out the possibility that some secreted promature protein is secreted in a semi-
processed state, there is strong evidence that a significant portion is in an unprocessed 
form, which was a possibility not taken into account in the Mottershead et al., 2015 study.  
In all four species included in this study, there was no evidence that mature or promature 
BMP15/BMP15 homodimers or BMP15/GDF9 heterodimers exist either within oocytes or 
as forms secreted from the oocyte (Figures 3.7-3.11). BMP15 and GDF9 lack the seventh 
cysteine residue that forms the disulphide bridge between two monomer subunits, 
presumably allowing for more flexible interactions between the monomer units (Chang et 
al., 2002; Shimasaki et al., 2004a). While a large number of studies have identified 
homodimers and heterodimers in recombinantly-produced forms of BMP15 and GDF9 
(Hashimoto et al., 2005; Liao et al., 2003; Liao, Moore, & Shimasaki, 2004; McIntosh et al., 
2008; Mottershead et al., 2015; Peng et al., 2013a; Shimasaki, Moore, Otsuka, & Erickson, 
2004b), there is no evidence to suggest these forms exist in vivo. There are a range of 
possible explanations for the absence of any dimer detection when using native oocyte 
produced proteins in this study. It is possible that dimers were present but below the 
threshold of detectability for Western blotting. To minimise this possibility, exposure times 
for Western blots were lengthened to increase the detectability of faint bands, yet still no 
dimer bands were detected. Another possibility is that the Mab61A antibody used had a 
lower affinity for dimeric forms of BMP15, however this is unlikely to be the case for mature 
BMP15 dimers as this antibody detected a mature homodimer in the recombinant HEK-293 
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produced pig BMP15 (positive control) after crosslinking in this study (Figures 3.7-3.10). It 
remains possible that the antibody target site in promature dimeric BMP15 forms are 
blocked because no promature dimers were detected, even using recombinant protein 
samples. However, this is unlikely due to crosslinked proteins being exposed to reducing 
conditions that should linearize the proteins and thus expose these sites. Finally, it is 
possible that native dimers are not stable under the collection conditions. Despite all these 
limitations, the absence of any BMP15 dimers under the conditions used in this study, 
together with the absence of any other evidence of native BMP15 dimer formation in the 
literature poses an interesting question about the differences between recombinant and 
oocyte produced (native) forms of BMP15 in regards to production and stability of BMP15 
dimers. 
This study also elucidated that at least some of the promature and mature BMP15 forms 
exist as monomers although this was species-specific. Whilst monomers existed in the 
oocyte lysates of all four species, secreted monomer forms were only detected pigs and 
deer as demonstrated by the presence of monomer bands following crosslinking (Figures 
3.7-3.10). Moreover, whilst mature BMP15 monomers were detected in secretions from 
oocytes of sheep, promature monomers were not. Possible monomer forms of BMP15 
have been observed following crosslinking using recombinantly-produced ovine and mouse 
BMP15 in previous studies (Edwards et al., 2008; McIntosh et al., 2008). As of yet, it remains 
unknown whether these native monomers are biologically active. Current evidence 
suggests that dimerization of BMP15 either with itself or with GDF9 is required at the level 
of the receptor for receptor activation and down-stream effects on granulosa cells. 
Moreover, it is reported that receptor complexes that include heterodimers elicit a 
stronger biological effect than homodimers in a number of species (Lin et al., 2006; 
McIntosh et al., 2008; Mottershead et al., 2015; Peng et al., 2013b). 
Whilst recombinant forms of BMP15, and GDF9, may not be identical to those observed in 
oocyte produced samples, they are valuable in determining why these differences may 
occur. From extrapolations of recombinantly-produced BMP15 and GDF9, it has been 
suggested that BMP15 and GDF9 heterodimers may spontaneously form either inside the 
oocyte, or in the extracellular space (Mottershead et al., 2015). The reasoning for this is 
that TGF-β monomers are highly hydrated at the dimerization interface, thus any 
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homodimers initially formed during protein production have limited stability. While other 
TGF-β superfamily members overcome this relative instability by forming a disulphide bond 
between the two monomers, the inability for BMP15 or GDF9 to form these bonds results 
in a mixture of dimers that are constantly exchanging monomer units (Mottershead et al., 
2015). While the model presented by Mottershead et al., 2015, suggested an equilibrium 
between BMP15 and GDF9 homodimers and heterodimers both inside and outside the 
oocyte, the results of this study suggest that the equilibrium may also include monomer 
units of either protein, and if dimers are forming, they may be transient in nature which 
may explain why no dimers were detected in this study. However, while this study allows 
for this possibility, it does not provide any direct evidence for transient dimer formation 
and further research into this possibility is required. If, with further research, the 
monomers detected do turn out to play a role in possible dimer formation and/or have 
bioactivity, then differences in the presence of these monomer forms may be species-
specific, and may influence litter size through differences in the bioavailability of monomers 
for potential dimer formation. This would have implications for the use of recombinant 
forms of BMP15 and GDF9 in protocols for in vitro maturation (IVM) of cumulus cell-oocyte 
complexes to increase oocyte quality and embryological outcome. The effective use of 
these growth factors in IVM may be heavily dependent on providing optimal extracellular 
conditions for weak transient dimers to form, and provision of the correct amount of their 
promature and mature monomer forms.  
Covalent, and possibly non-covalent, multimers were observed in the oocyte lysates of all 
four species, and in the oocyte conditioned media of deer, pigs and sheep as indicated by 
the presence of prominent bands in the 150-250 kDa region under crosslinking and/or non-
reducing conditions (Figures 3.7-3.10). Where multimers were observed, similar molecular 
weight bands were observed in the anti-GDF9 labelled samples suggesting the presence of 
BMP15/GDF9 multimers. The broad multimer band on the Western blot suggests a range 
of different multimeric compounds and has been observed in previous studies using 
recombinant proteins (Edwards et al., 2008; McIntosh et al., 2008; Mester, 2013; Reader 
et al., 2011). It was proposed that the multimers contain combinations of proregion and 
mature proteins of BMP15 and GDF9, and that the proregion may be important in multimer 
formation; however the precise components of the multimers remained largely undefined. 
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It also remains a possibility that the multimer bands are simply an artefact caused by the 
Western blot methodology.  
The molecular weights of the promature and mature bands in this study were generally less 
than those observed in previous studies using recombinant BMP15 (Hashimoto et al., 2005; 
McIntosh et al., 2008; McMahon et al., 2008; Reader et al., 2011). However, recombinant 
forms of sheep, deer and pig BMP15 used in the current study had similar molecular 
weights to the corresponding native forms, and thus these discrepancies are likely to be 
due to methodology differences or differences between molecular weight ladders. 
Interestingly, the molecular weights of the promature and mature bands for each species 
were ~5 and ~2kDa heavier than the expected calculated weight based on the amino-acid 
sequence alone (“ExPASy - Compute pI/Mw tool,” 2016). This may be due to the proteins 
being glycosylated and/or phosphorylated as promature and mature BMP15 has five and 
two potential glycosylation sites respectively, and both may be phosphorylated (Dube et 
al., 1998; McMahon et al., 2008). Protein glycosylation may explain the band laddering 
effect observed in sheep, deer and pig oocyte lysate samples, and the double bands present 
in oocyte conditioned media samples in this study. It has been reported that glycosylation 
and/or phosphorylation may alter the bioactivity of BMP15 proteins (McIntosh et al., 2008; 
McMahon et al., 2008). Thus, the prominent laddering observed in the species with a low 
litter size (sheep and deer) compared to the faint or no laddering observed in the species 
with high litter size (pig and rat) may indicate differential post-transcriptional processing of 
BMP15 in high and low litter size species, and thus differences in the bioactivity of the 
BMP15 present. In this present study, chemical deglycosylation experiments were 
attempted using a modified version of a previously-published protocol (Horvath et al., 
1989) however, the protein lost during the deglycosylation process together with only 
nanogram quantities of starting material resulted in no identifiable bands (data not shown). 
In future studies, an enzymatic deglycosylation of the BMP15 may be more suitable.  
When assessing protein forms on a Western blot, it is often difficult to assess which bands 
are due to specific binding of the antibody. Monoclonal antibodies are designed to be 
highly specific towards their target sequence, however it is possible for non-specific target 
sites to exist (Frank, 2002; Holmseth et al., 2012). Preadsorption experiments were 
performed using E.coli-produced ovine BMP15 which led to a complete loss of bands at all 
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of the expected BMP15 sizes but also in additional bands. The disappearance of bands 
following preabsorption has traditionally been used to test specific binding of polyclonal 
antibodies. However in this case, Mab61A was a monoclonal antibody, and preadsorbtion 
was performed using the same target antigen (E. coli produced mature ovine BMP15) that 
it was screened against during production. Therefore, unlike with polyclonal antibodies, all 
bands, regardless of specificity, would be expected to disappear (Holmseth et al., 2012; 
Saper, 2009). Furthermore, stripping of Western blots leads to protein loss (Appendix IV), 
and thus faint bands in original blots may have been lost through this process.  
 
4.3 The relative amounts of promature and mature BMP15 
across a range of mammalian species with different litter 
sizes (rats, sheep, deer and pigs) 
 
Of the two different methods for normalising the relative amounts of BMP15 illustrated in 
Figures 3.13 and 3.14, the method whereby values were presented relative to the number 
of oocytes per sample and normalised using the mature BMP15 band in the positive control 
(Figure 3.14) was deemed most appropriate for detailed discussion, and the reasons for 
this are described later in this discussion section. 
There was markedly more promature and mature BMP15 observed in the oocyte lysates of 
deer compared to the other three species (Figure 3.14 A). This indicates that that BMP15 
may play a greater role in follicular growth and maturation in deer than in the other species 
tested. There were moderate levels of both molecular forms of BMP15 in the sheep, but 
very low levels in the rat. These results align well with previous research suggesting that 
BMP15 is essential for low ovulation rate species, and may be less important in some high 
ovulation rate species (Galloway et al., 2000; Hanrahan et al., 2004; Yan et al., 2001). The 
BMP15 levels within the pig oocyte lysate did not conform to this trend, as the levels of 
each protein form were similar to sheep. It was previously reported that both BMP15 and 
GDF9 mRNA expression levels per oocyte are high in the pig compared to sheep, deer or 
rats (Crawford & McNatty, 2012). The BMP15 mRNA expression of pigs was ~4-6 fold higher 
than sheep or deer, and ~18 fold higher than rats. In this current study, the protein levels 
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of BMP15 were lower than deer and similar to sheep. This suggests that species differences 
in the post-transcriptional processing of BMP15 occur, and it raises the possibility that the 
GDF9:BMP15 protein ratio in pigs may be more in-line with what is expected in a high 
ovulatory species. Further investigation is required to determine if this is the case. 
Regardless, these results clearly indicate that BMP15 protein levels within oocytes alone 
do not correlate with litter size for all species.  
The secreted forms of promature BMP15 were higher in deer than sheep and rats, but 
similar to that in pigs (Figure 3.14 B). Unlike the oocyte lysate samples, the levels of mature 
protein in the oocyte conditioned media samples were similar between deer, sheep and 
pigs. Whilst this suggests that the levels of mature BMP15 produced within an oocyte do 
not necessarily correlate with that secreted, it may be due to a lack of sensitivity of the 
Western blotting technique. 
The promature:mature BMP15 ratios in the oocyte lysates were similar in the two low 
ovulation rate species (sheep and deer), and similar in the two high ovulation species (pig 
and rat), with the ratio being markedly higher in the low ovulation species (Figure 3.15). 
The lower ratio in the species with large litter sizes does not conform well with a number 
of studies whereby mutations that lowered promature BMP15 processing (i.e. increased 
the promature:mature ratio) led to higher fertility (Hanrahan et al., 2004; Hashimoto et al., 
2005; Shimasaki et al., 2004). These anomalies may be partially explained by the fact that 
both pigs and rats have mutations in the RXXR cleavage region resulting in unique residues 
in the XX portion of the furin-like protease cleavage site while sheep and deer both share 
the RRAR cleavage sequence. This may results in differences in processing efficiencies of 
the furin-like proteases involved in the cleavage process in rats and pigs, compared to 
sheep and deer.  
There was no differences between the ratios of secreted promature:mature forms in the 
sheep, deer and pig, with the ratio declining markedly in each species compared to what 
was observed within the oocyte (Figure 3.15). The decline in the promature:mature ratio 
in the forms secreted outside of the oocyte suggests that the promature form may be less 
readily secreted than the processed mature form, which has been suggested previously 
(Shimasaki et al., 2004), or that the processing of the promature protein occurs more 
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rapidly outside of the cell. Another possibility is that extracellular protease activity under 
in-vitro conditions led to increased promature processing. While protease inhibitors were 
added after the incubation of the oocytes, protease activity in the conditioned media may 
still have occurred during the incubation period. This possibility is supported by studys that 
revealed that only the unprocessed promature form was present in follicular fluid of sheep 
(McNatty et al., 2006), while processed and unprocessed forms were detected in media 
from in-vitro culturing of sheep oocytes (Lin et al., 2012, this study).  
As mentioned earlier, two different methods for normalizing BMP15 results were explored 
in this study which are displayed in Figures 3.13 and 3.14, and described in Section 2.1.6.  
The principle behind normalizing the bands against β-actin levels was that β-actin acts as a 
house-keeping protein (HKP) in oocytes, and as such, it is assumed that β-actin levels are 
relative to total protein levels (Ferguson et al., 2005). Furthermore, β-actin is a highly 
conserved protein (Gunning et al., 2015; Rubenstein, 1990), and as such, the same antibody 
could be used to detect β-actin in each species in this study. However, a number of 
deficiencies were identified using this method in this study. Firstly, β-actin, like many HKPs 
has been shown to have inconsistent translation efficiency across tissue types and sample 
conditions (Ferguson et al., 2005; Li & Shen, 2013). Secondly, β-actin was highly abundant 
in the oocyte lysate samples therefore shorter exposure times were used to avoid image 
saturation, common for HKP in cell lysate samples (Taylor & Posch, 2014). These shorter 
exposure times will decrease the sensitivity of this method. Thirdly, β-actin is not secreted 
and thus absent in the conditioned media samples. Therefore, values from the 
corresponding oocyte lysate samples were extrapolated to corresponding media samples 
however transfer and loading efficiencies between the sample types were unknown. Finally 
and most importantly, there were species differences in the ease of denuding oocytes, and 
as such, oocytes from pigs were fully denuded of cumulus cells, whilst the others were 
partially denuded. Therefore, β-actin levels in oocyte samples from rats, sheep and deer 
also contained cumulus cell-derived β-actin. This would result in higher β-actin levels in 
these species and result in low normalised values of BMP15, as observed Figure 3.13. 
An alternative approach used was to express the density result per oocyte, and normalise 
against the density value of the mature BMP15 band in the positive control that was 
present in every blot. This also accounted for inter-blot variation due to different transfer 
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and labelling efficiencies between blots. This approach also had several limitations. It did 
not control for differences in transfer and loading efficiency across all of the lanes present 
in each blot. It also relies on the consistent loading of the positive control between blots. 
Despite these limitations, it appeared to provide a way for semi-quantifying and comparing 
the amount of BMP15 within, and secreted from, oocytes in the different species. 
 
 
89 
 
4.4 Study Conclusions  
 
This study clearly demonstrated species differences in the molecular forms of BMP15. Deer, 
sheep and rats conform to the hypothesis that BMP15 levels are inversely related to litter 
size. That is, the intra-oocyte levels, and largely the secreted levels, of BMP15 ranked from 
highest to lowest were that in deer, sheep and rats, respectively. Pigs were an exception 
whereby their oocytes contained similar levels of BMP15 to sheep. As expected, secreted 
forms of rat BMP15 were negligible. These results imply that BMP15 may play a role in 
follicular growth and maturation in some high ovulation rate species, as well as low 
ovulation rate species. Overall, these results suggest that levels of BMP15 are not the sole 
determinant of litter size. 
The current study failed to detect BMP15/BMP15 homodimers or BMP15/GDF9 
heterodimers in any of samples collected from the four species. Monomers of promature 
and mature BMP15 were detected, as well as possible multimeric forms. The detection of 
dimers in recombinantly-produced BMP15 suggests that there are differences between 
recombinantly-produced and native forms of BMP15. Therefore, conclusions made from 
studies using recombinant BMP15 may not necessarily provide a fair representation of the 
forms, and thus biological activity of BMP15, in vivo. 
This study showed that the monoclonal antibody Mab61A was suitable for the detection of 
the different molecular forms of BMP15 in numerous species. Comparisons between two 
monoclonal antibodies highlighted the variability in affinities that can occur when 
generated using different methods (whole protein versus short peptide sequence), even 
when the target sequences overlap. This study emphasises the importance of testing 
multiple antibodies before making conclusions about protein forms present within 
Western blot assays.  
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4.5 Future Directions 
 
To fully appreciate the findings of this study, it would be useful to repeat the Western blot 
experiments and immuno-label for GDF9. By keeping experimental conditions similar but 
optimising for oocyte number in regards to GDF9 production, it would be possible to 
compare the relative amounts of each protein, and determine how the GDF9:BMP15 
protein ratios relate to a previous study that reported Gdf9:Bmp15 mRNA ratios in the 
same species (Crawford & McNatty, 2012). Of particular interest would be whether the 
GDF9:BMP15 protein ratio is similar to the low Gdf9:Bmp15 mRNA ratio observed in pigs.  
It would be useful to collect larger sample sizes and concentrate the samples using 
immunoprecipitation. The concentrated levels of BMP15 in the samples, particularly in the 
oocyte conditioned media, would allow for better detection of lowly-translated proteins. It 
may also allow for the detection of dimer forms if present, or more conclusively prove their 
absence. Furthermore, the development of purified mutated recombinant forms of 
covalently bound promature and mature BMP15/BMP15 homodimers, and BMP15/GDF9 
heterodimers for each species would confirm whether the Mab61A antibody is capable of 
detecting these dimers. This would support the results from this study by determining 
whether or not the absence of dimer forms was due to the limitations of the antibody. Also, 
further investigation of the multimer complexes using 7.5% acrylamide gels and a range of 
different antibodies may provide insight into the different non-monomer protein forms 
present.   
Posttranslational modifications such as glycosylation and phosphorylation have often been 
suspected of having a role in BMP15 bioactivity. It was hypothesised that the laddering of 
bands in several blots may be due to posttranslational modifications of the protein. While 
chemical deglycosylation proved unsuccessful and led to a complete loss of protein, 
deglycosylation using an enzyme such as PNGase F may be more successful. This would 
provide insight into whether glycosylation levels vary between species, and between 
recombinant and native oocyte-produced forms of BMP15. Finally, a similar set of 
experiments using a greater range of mammalian species that differ in litter size may help 
determine whether the general hypothesis that BMP15 levels are inversely related to litter 
size is valid. 
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Appendices 
Appendix I. Materials 
 
Table 1:  Labware  
 
  Source/Manufacturer 
Autoclave - Systec DX 65 Systec 
Balance - 573-36NM Precision Balance Kern 
Balance - Mettler XS205 Dual Range Analytical 
Balance 
Mettler Toledo 
Cell Strainer 100μm Falcon (a Corning Brand) 
Cell Strainer 40μm, 70μm Fisher Brand 
Centrifuge - Centrifuge 5810R Eppendorf 
Centrifuge - Minispin Plus Eppendorf 
Centrifuges tubes -Centristar 15 mL, 50 mL Corning Incorporated 
Criterion Blotter with Plate Electrodes  
(Cat #1704070) 
Bio-Rad 
Kimwipes - Kimtech Science Brand Kimberly-Clark 
Fridge -20°C - Tefcold Tefcold - supplied by Inter-fridge 
Fridge 4°C - Tefcold Tefcold - supplied by Inter-fridge 
Fridge -80°C - Sanyo Ultralow VIP Series Global Science (VWR), Sanyo 
Fume Cupboard - Labrocare Thermoplastic Engineering Ltd. 
Gel Blotting Paper - GB003 Whatman Schleicher & Schuell 
Glass Beakers 2000 mL, 500 mL, 100 mL Duran 
Glass Bottles 100 mL, 500 mL, 200 mL, 100 mL Duran 
Graduated Microtubes 1.5 mL, 0.65 mL Scientific Specialties Inc. (SSI) 
ImageJ Software U. S. National Institutes of Health 
Imaging System - Omega Lum G Aplegen 
Incubator - Incusafe Global Science (VWR) 
Laminar Flow - NuAire NU-437-400, class II, Type 
A2 Biosafety Cabinet 
NuAire 
Magnetic Stirrer - RCT Basic IKA 
Membrane - Amersham Protran nitrocellulose 
blotting membrane 
GE Healthcare Life Sciences 
Microtube Cap Locks Scientific Specialties Inc. (SSI) 
Mini-PROTEAN Tetra Cell Casting Module Bio-Rad (Catalogue number 165-8008) 
Mini-PROTEAN II Tetra Electrophoresis System Bio-Rad (Catalogue number 165-8000) 
Needles - Precision-glide 26G, 20G, 18G BD 
Parafilm “M” Laboratory Film Pechiney Plastic Packaging 
Petri Dish 100mm- Nunclon Delta Treated Thermo Scientific 
Petri Dish 35mm Biofil 
Petri Dish 60mm Citotest 
pH meter - SevenEasy, with InLab Expert Pro 
electrode 
Mettler Toledo 
Pipette P100  Axygen 
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Pipette P1000  Gilson 
Pipette Pump (manual) Bel-Art- SP Scienceware 
Pipette tips (all sizes) - Eclipse pipette tip refill 
system 
Labcon 
Pipettes P10, P2, P25, P300  Hamilton 
Pipetting Aid (Battery operated) - Easypet Eppendorf 
Plastic containers for labelling membrane with 
antibody - No 49106 PP 
Uniware 
Plastic containers for stripping membranes 
(sealable) Klip ItTM 200 mL 
Sistema 
Power Supply- PowerPac HC Biorad 
Prism Software Version 5 Graphpad 
Rubber Gloves - micro-touch Dermaclean Ansell 
Scissors- dissection World Precision Instruments Inc. (WPI) 
See-saw rocker - SSL4 Stuart 
Serological Pipettes - Costar Stripette 5 mL, 10 mL, 
25 mL 
Corning Incorporated 
Shaker Low Speed - Orbit LS Labnet 
Stereo Microscope Leica MZ9S, with Leica MDG-28 
light base   
Leica 
Syringe Filter 0.45μm - Minisart Sartorius Stedim Biotech 
Syringes - Luer-Lok tip 1 mL, 3 mL, 5 mL, 10 mL  BD 
Transparency Film 3M 
Tweezers - dissection World Precision Instruments Inc. (WPI) 
Vacuum Driven Sterile Filter - Millipore Express 
Plus Steritop 
Millipore 
Vibrating Stirrer Vibrax VXR Basic IKA 
Vortex - Wisemix VM-10 Wisd Laboratory Instruments 
Water Bath- Lab Companion BW-1 Lab companion- Supplied by Bio-strategy 
Water Still- High-Q 103S High-Q Inc. 
 
 
 
 
 
Table 2:  Reagents and Materials 
 
Reagents/materials 
Storage 
conditions 
Source/Manufacturer 
2-mercapto-ethanol (2-ME) Room Temp Sigma Life Sciences 
30% Acrylamide/Bis Solution 4°C Bio-Rad 
Ammonium persulfate (APS) Room Temp Sigma-Aldrich 
Bissulfosuccinimidyl suberate (BS3) 4°C Thermo Scientific 
Bromophenol blue sodium salt Room Temp Sigma-Aldrich 
Complete EDTA-free Protease inhibitor cocktail 
tablets 
4°C Roche 
Dithiothreitol (DTT) - Electrophoresis Purity 4°C Bio-Rad 
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E. coli.  produced mature GDF9 - Sheep  in 2M 
urea pH 8 
-20°C In-House 
E. coli. produced mature BMP15 - Sheep in 2M 
urea pH 8 
-20°C In-House 
Glycerol - 99% for molecular biology Room Temp Sigma-Aldrich 
Glycine - Reagent Grade Room Temp Scharlau 
HCl 36% Room Temp APS Chemicals 
HEK-293 BMP15 Recombinant Conditioned 
Media - Deer 
-80°C long 
term, -20°C 
short term 
In-House 
HEK-293 BMP15 Recombinant Conditioned 
Media - Pig 
-80°C long 
term, -20°C 
short term 
In-House 
HEK-293 BMP15 Recombinant Conditioned 
Media - Sheep 
-80°C long 
term, -20°C 
short term 
In-House 
HEK-293 GDF9 Conditioned Media - Pig 
-80°C long 
term, -20°C 
short term 
In-House 
HEK-293 Untransfected Conditioned Media 
-80°C long 
term, -20°C 
short term 
In-House 
HEPES Room Temp Sigma-Aldrich 
Ladder -  Precision Plus Protein Dual Color 
Standards CL1610374 Rev H 
-20°C Bio-Rad 
Ladder - Kaleidoscope Prestained Standards 
CL1610324 Rev F 
-20°C Bio-Rad 
Ladder - Prestained SDS-PAGE Standards, 
broad Range CL1610318 Rev E 
-20°C Bio-Rad 
Medium 199 500 mL - + Earle's Salts, + L-
Glutamine, + 2.2g/L Sodium Bicarbonate 
4°C Gibco (Thermo Fisher Scientific) 
Medium 199, powder - M5017 +Earle's salts +L 
Glutamine 
4°C Sigma-Aldrich 
Methanol - AnalaR Normapur Room Temp VWR Prolabo 
NaOH   
PBS -1X pH 7.4 4°C Gibco (Thermo Fisher Scientific) 
Penicillin-Streptomycin -5°C Gibco (Thermo Fisher Scientific) 
Peptide B - order id 15859-3, lot 
#158501003012412ZW, Peptide Sequence: 
QAGSIASEVPGPSRC  
-20°C GenScript 
Ponceau S Room Temp BDH  
Sodium azide Room Temp Scharlau 
Sodium Chloride (NaCl) - Reagent grade Room Temp Scharlau 
Sodium dodecyl sulfate (SDS) Room Temp Fisher Chemicals 
TEMED Room Temp Bio-Rad 
Tris base - biology grade Room Temp Applichem 
Tween20 Room Temp Fisher Bioreagents 
WesternBright ECL-Spray Western Blotting 
Detection System  
Room Temp Advansta 
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Table 3: Recipes 
 
Solution Recipe Storage Conditions 
0.5M Tris-HCl pH 6.8 
6.06g Tris Base dissolved in 80 mL 
High-Q water. Adjusted to pH 6.8 
with concentrated HCl then made up 
to 100 mL with High-Q water. 
Room temp in Duran glass bottle (up 
to one month) 
1.0M Tris-HCl pH 7.5 
30.29g Tris Base dissolved in 200 mL 
High-Q water. Adjusted to pH 7.5 
with concentrated HCl then made up 
to 250 mL with High-Q water. 
Room temp in Duran glass bottle (up 
to one month) 
1.5M Tris-HCl pH 8.8 
36.34g Tris Base dissolved in 160 mL 
High-Q water. Adjusted to pH 8.8 
with concentrated HCl then made up 
to 200 mL with High-Q water. 
Room temp in Duran glass bottle (up 
to one month) 
10% (w/v) APS 
1g ammonium persulphate dissolved 
in High-Q water  to give 10 mL final 
volume 
-20°C in Graduated Microtubes (up to 
6 months) 
10% SDS 
20g SDS dissolved in High-Q water to 
give 200 mL final volume 
Room temp in Duran glass bottle (up 
to one month) 
10x tris-glycine stock 
30.3g Tris base 
144g Glycine  
High-Q water added to give 1L final 
volume when fully dissolved 
Room temp in Duran glass bottle (up 
to one month) 
2x Modified laemmli 
non-reducing LB 
1.0 mL 0.5M Tris HCl pH 6.8 
4.5 mL Glycerol 
4.6 mL 10% SDS 
0.4 mL 1% (w/v) bromophenol blue 
4.5 mL High-Q water 
-20°C in Graduated Microtube aliquots 
(up to 3 months) 
2x Modified laemmli 
Reducing loading buffer 
1.0 mL 0.5M Tris HCl pH 6.8 
4.5 mL Glycerol 
4.6 mL 10% SDS 
0.4 mL 1% (w/v) bromophenol blue 
4.5 mL High-Q water 
80 mg DTT 
1.66 mL 2ME (added fresh) 
-20°C in Graduated Microtube aliquots 
without 2ME (up to 3 months).  
2ME stored at room temp and added 
fresh (10% of total volume) 
immediately before use 
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BS3 Crosslinking solution 
(7X) 
0.8 mg BS3 
Dissolved in High-Q water to give 
100μL final volume (gives 14mM 7X 
stock solution) 
Prepared fresh immediately before use 
M199 Media for 
collection 
9.5g (1 jar) M199 m5017 media 
powder 
10 mL Pen/Strep 
4.766g HEPES 
800 mL High-Q water 
Adjusted to pH 7.3 with 2M NaOH  
More High-Q water added to give 1L 
final volume then filtered through 
Millipore Express Plus Steritop sterile 
filter 
4°C in Duran glass bottle sealed with 
Parafilm (up to 1 month) 
 
Only opened in Laminar Flow and 
aliquoted into 50 mL centrifuge tubes 
prior to use 
M199 Media for 
incubation 
Medium 199 500 mL (+ Earle's Salts, 
+ L-Glutamine, + 2.2g/L Sodium 
Bicarbonate) 
5 mL Pen Strep 
4°C in Gibco 500 mL media bottle 
sealed with parafilm (up to 1 month) 
Only opened in Laminar Flow and 
aliquoted into a 15 mL centrifuge tube 
prior to use 
Membrane wash buffer 
20 mL 1M Tris-HCL pH 7.5 
8.76g NaCl 
1 mL Tween20 
High-Q water to give 1L final volume 
 
Room temp in Duran glass bottle (up 
to one month) 
Ponceau S stain 
1.0g PonceauS 
2.0 mL Acetic acid 
High-Q water to give 200 mL final 
volume 
Room temp in Duran glass bottle (up 
to 6 months) 
Protease inhibitor 
solution (10X stock) 
1X Complete EDTA-free Protease 
inhibitor cocktail tablet 
5 mL High-Q water 
Stored in aliquots at  
-20°C (up to 6 months) 
Aliquots thawed prior to use and 
thawed aliquots were kept up to 2 
weeks at 4°C before disposal 
Saline solution (0.9%) 
9.0g NaCl 
Add High-Q water to give 1L final 
volume 
Autoclaved 
Room temp in Duran glass bottle (up 
to one month) 
Stripping buffer 
20 mL 10% SDS 
12.5 mL 0.5M Tris-HCl pH 6.8 
0.7 mL 2ME 
Add 66.8 mL High-Q water to give 
100 mL final volume 
Made fresh before use 
Transfer buffer 
200 mL 10X Tris-Glycine stock 
400 mL Methanol 
1400 mL High-Q water 
4°C in Duran glass bottle up to 2 
months 
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Table 4: Antibodies Summary 
 
Antibody 
Lot 
Number 
Target Sequence 
Storage 
conditions 
Source 
Anti β-Actin 
 
Monoclonal Anti  
β-Actin Ab produced in 
mouse (IgG1) 
(Product # A5441) 
030M4788 
 
DDDIAALVIDNGSGK 
conjugated to KLH 
-20°C in liquid 
of processed 
mouse ascites 
fluid and 
15mM sodium 
azide 
Sigma-Aldrich 
HRP-conjugated antibody 
 
Peroxidase-conjugated 
Affinipure Rabbit Anti-
mouse IgG (H+L) 
(peroxidase purified from 
horseradish root) 
119936 
Reacts with whole 
molecule mouse IgG and 
the light chains of other 
mouse immunoglobulins 
-20°C stored 
at 0.4 mg/mL 
in equal parts 
High-Q water 
and glycerol  
Jackson 
ImmunoResearch 
Laboratories Inc. 
Mab61A 
 
Anti BMP15 (Targeted at 
N-terminal flexible region 
of mature peptide in 
sheep) 
N/A 
SEVPGPSREHDGPES 
sequence towards N-
terminal of mature ovine 
BMP15.  
4°C in 
PBS/0.1% 
sodium azide 
Oxford Brookes 
University in the 
United Kingdom 
under contract to 
AgResearch 
Mab61B 
 
Anti BMP15 (Targeted at 
N-terminal flexible region 
of mature peptide in 
sheep) 
N/A 
QAGSIASEVPGPSR(C) 
sequence at N-terminal 
of mature ovine BMP15. 
Cysteine residue 
(underlined) used to 
chemically conjugate 
sequence to KLH 
4°C in 
PBS/0.1% 
sodium azide 
by GenScript®, USA 
under contract to 
Victoria University 
of Wellington 
Mab37A 
 
Anti GDF9 (Targeted at N-
terminal flexible region of 
mature peptide in sheep) 
N/A 
DQESASSELKKPLV(C) 
sequence at N-terminal 
of mature ovine BMP15. 
Cysteine residue 
(underlined) used to 
chemically conjugate 
sequence to KLH 
4°C in 
PBS/0.1% 
sodium azide 
Oxford Brookes 
University in the 
United Kingdom 
under contract to 
AgResearch 
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Appendix II.  Antibodies 
 
Mab61A- Anti-BMP15 
Mab61A was a mouse generated monoclonal antibody (IgG) created to target BMP15 and 
was made by Oxford Brookes University in the United Kingdom under contract to 
AgResearch according to the protocol in Juengel et al., 2002. The methods described 
outbred Tyler’s original mice being immunized with full length E. coli. produced mature 
ovine BMP15 protein in Freund complete adjuvant. Positive clones were screened by ELISA 
using HEK-293 produced ovine BMP15 conditioned media and the best clone was selected 
(McNatty et al., 2005a). The supernatant of the best clone, which contained Mab61A, was 
then purified using protein G affinity purification.  It was later determined that the Mab61A 
antibody targets a 15 amino acid sequence towards the N-terminus of the mature peptide, 
SEVPGPSREHDGPES (see Appendix II Figure 1) (McNatty et al., 2005a). The region where 
the target sequence (SEVPGPSREHDGPES) is located is predicted to be a flexible region with 
unknown function based on a BMP15 dimer model previously described (Juengel & 
McNatty, 2005; McNatty et al., 2007). In one study, the same 15 amino acid peptide was 
conjugated to Keyhole limpet hemocyanin (KLH) via a C-terminal cysteine residue, and then 
used in in-vivo immunization experiments in sheep where it was shown to elicit a strong 
immune response which in turn inhibited ovarian function (McNatty et al., 2007). This was 
evidenced by a significant decline in the number of corpus luteum following immunization 
with the peptide, as well as an increase in abnormal follicle morphology (McNatty et al., 
2007). Mab61A has been used to successfully immuno-neutralise and inhibit the bioactivity 
of ovine BMP15 in vitro (Lin et al., 2012). 
 
Mab61B- Anti-BMP15 
Mab61B was also a mouse generated monoclonal antibody (isotype IgG1,K) which was 
created to target BMP15 and was made by GenScript®, USA under contract to Victoria 
University of Wellington.  It was generated in mice using a synthesized 14 amino acid 
sequence from the N-terminal of the mature ovine BMP15 sequence which was conjugated 
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to KLH via a cysteine residue (QAGSIASEVPGPSR(C)-KLH) (see Appendix II Figure 1). Positive 
clones in supernatant samples were screened by ELISA using the same 15 amino acid 
sequence (QAGSIASEVPGPSRC) without the KLH attached and the best clone was selected.  
The supernatant of the best clone which contained Mab61B was then purified using protein 
A/G affinity purification. The Mab61B target sequence shared similar properties to the 
Mab61A target sequence due to their close proximity. It is predicted to be in a flexible 
region of the mature peptide in a region with unknown function based on a BMP15 dimer 
model (Juengel & McNatty, 2005; McNatty et al., 2007). An in-vivo study that used the same 
peptide-KLH immunogen which was used to generate Mab61B (QAGSIASEVPGPSR(C)-KLH) 
was used to successfully immunize sheep, and the associated immune response was shown 
to strongly inhibit ovarian function (McNatty et al., 2007). The effect of immunizing with 
the Mab61B target sequence was even more disruptive to ovarian function than the effect 
of immunization with the Mab61A target sequence as evidenced by a marked decline in 
the number of corpus luteum over a shorter time period following immunization (Kenneth 
P. McNatty et al., 2007). Eight amino acids in the Mab61B target sequence overlap with the 
Mab61A target sequence (see Appendix II Figure 1). 
 
Mab37A- Anti-GDF9 
Mab37A is a mouse generated monoclonal antibody (IgG) which was made by Oxford 
Brookes University in the United Kingdom under contract to AgResearch. The antibody was 
generated using full length E. coli. produced mature ovine GDF9 protein along with Freund 
complete adjuvant. Mab37A has been shown previously to specifically bind ovine GDF9, 
and to be able to detect the promature and mature forms of the protein (Lin et al., 2012; 
McIntosh et al., 2008; McNatty et al., 2005a). It has not previously been established 
whether the antibody can inhibit GDF9 bioactivity in vitro. During the antibody production 
and characterisation process it was determined that there was some cross reactivity with 
ovine BMP15 (data not published). The specific target region of Mab37A on the mature 
ovine GDF9 molecule has not been established. 
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Appendix II Figure 1. The mature BMP15 target sequences for Mab61A and Mab61B. Black boxes 
around individual amino acids indicate differences from the original sheep target sequence. The colours 
of the residues indicate the properties as shown by the key in the figure. The level of homology shared 
with the original sheep target sequence is indicated next to each sequence. (A) The 15 amino acid target 
sequence for Mab61A in mature sheep BMP15 is displayed alongside the equivalent region of mature 
BMP15 in rats, pigs and deer. The target sequence is located 6 amino acids in from the N-terminal of the 
mature BMP15 peptide. (B) The 15 amino acid target sequence for Mab61B in mature sheep BMP15 is 
displayed alongside the equivalent region of mature BMP15 in rats, pigs and deer. The target sequence 
is located directly at the N-terminal of the mature BMP15 peptide. The asterisk (*) and bracket indicate 
the 8 amino acid region where the targets of each antibody overlap.  
 
Appendix III. Recombinant BMP15 and GDF9 Samples  
 
The recombinant BMP15 conditioned media samples were generated in-house at Victoria 
University Wellington. 
 The HEK-293 samples were generated by transferring the genes for the required protein into 
the pEFIRES-P expression vector (Hobbs, Jitrapakdee, & Wallace, 1998), and then transfected 
into a human embryonic kidney cell line (HEK-293). High recombinant protein expressing 
clones were selected and the protein samples were collected in serum-free harvesting 
medium (DMEM/Ham’s F-12, 1:1) with l-glutamine, penicillin, streptomycin, 0.01% BSA and 
heparin added as described in McNatty et al. (2005a).  
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Escherichia coli (E. coli) produced recombinant protein samples were generated by 
transferring the cDNA mature BMP15 sequence into the pET23b expression vector. The 
vector was then transformed into  BL21DE3 E. coli cells which were then used for protein 
production as described in Juengel et al. (2002). 
 
Appendix IV. Example of full blot from Figure 3.11 
 
 
 
Appendix IV Figure 1. Full blots representing sheep BMP15 and GDF9 under reducing conditions. (A) 
A sample of a full Western blot from Figure 3.11 representing BMP15 in sheep oocyte samples under 
reducing conditions. The blot was labelled with the anti-BMP15 antibody Mab61A. Lane 1 contains 2μL 
of recombinant HEK-293 produced pig BMP15 conditioned media (positive control), Lane 2 contains the 
lysate from 100 sheep oocytes, Lane 3 contains the conditioned media from 125 sheep oocytes, Lane 4 
contains 2μL of recombinant HEK-293 produced pig GDF9 conditioned media (negative control). (B) 
Represents the same blot from (A) after it has been stripped twice and labelled with the anti-GDF9 
antibody Mab37A. Lane 4 now represents the positive control and Lane 1 represents the negative 
control. The positions of the promature and mature forms of each protein are indicated on the side of 
each blot. 
 
